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ABSTRACT 
 
 
 
Rogers, Megan P. M.S., Purdue University, May 2015. Investigation of the 
Evolutionary Aspects of Thiamin Diphosphate-Dependent Decarboxylases. Major 
Professor: Michael J. McLeish. 
 
 
 
Thiamin diphosphate (ThDP)-dependent enzymes catalyze a wide range of 
reactions including the oxidative and nonoxidative decarboxylation of 2-keto acids, 
carboligation reactions, the cleavage of C-C bonds, and the formation of C-S, C-N, and 
C-O bonds.  Surprisingly, given this diversity, all ThDP-dependent enzyme catalyzed 
reactions proceed through essentially the same intermediate. This suggests that 
these enzymes share a common ancestry and have evolved to become the diverse 
group of enzymes seen today.  
Sequence alignments have revealed that all ThDP-dependent enzymes share 
two common ThDP binding domains, the PYR domain and the PP domain. In 
addition to these conserved domains, over time, other domains have been added 
creating further diversity in this superfamily. For instance, the TH3 domain, found 
in many ThDP-dependent enzymes, serves the function of binding additional 
cofactors such as FAD in enzymes like acetohydroxyacid synthase (AHAS) but in 
others, like pyruvate decarboxylase (PDC), it has lost this function completely.  The 
work presented here focuses on ThDP-dependent decarboxylases. In this thesis, 
xv 
 
x
v
 
several evolutionary aspects of this group of enzymes will be examined including (i) 
the characterization of an evolutionary forerunner in the presence of a mechanism-
based inhibitor, (ii) the characterization of the minor isozymes of pyruvate 
decarboxylase from Saccharomyces cerevisiae, and (iii) the development of a 
selection method to increase the efficiency of the site-saturation mutagenesis used 
to study ThDP-dependent enzyme evolution.  
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CHAPTER 1. INTRODUCTION 
 
 
 
1.1 Thiamin Diphosphate 
Organisms require a variety of different nutrients to help maintain 
optimal functioning. However, not all nutrients can be synthesized and therefore 
must be obtained through diet. Many of these essential nutrients are known as 
vitamins; a deficiency in any particular vitamin can lead to disease. For instance, 
a deficiency in vitamin B1 or thiamin in humans can lead to beriberi, a disease 
that affects the cardiovascular and nervous systems. Although vitamins have 
different roles in the body, many, including B1, act as enzyme cofactors.   
Thiamin diphosphate (ThDP), the biologically active form of vitamin B1, 
is utilized as a cofactor by a variety of enzymes carrying out a large range of 
reactions. Although ThDP is a cofactor, it also acts as a catalyst when it is not 
bound to an enzyme, but these reactions occur extremely slowly (1).  
ThDP (Figure 1.1) consists of a pyrimidine ring (left) that is connected to 
a thiazolium ring (center) through a methylene carbon. The thiazolium ring is 
substituted with a methyl group and also a β-ethyldiphosphate group (right).  
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Figure 1.1. Structure of ThDP in the 4’-aminopyrimidine (AP) form. 
 
The structure in Figure 1.1 is known as the 4’-aminopyrimidine (AP) form of 
ThDP. This form exists in equilibrium with the 1’, 4’-iminopyrimidine (IP) form 
(Figure 1.2) (1). In order for catalysis to occur, ThDP must be in the activated 
form known as the ylide. 
 In all ThDP-dependent enzymes, with the exception of glyoxylate 
carboligase (2), there is a conserved glutamate residue that assists in the 
formation of the ylide (Figure 1.2).  When ThDP is in the IP form, the glutamate 
residue abstracts a proton from the 1’ nitrogen. This permits the hydrogen on 
the C2 atom to be abstracted by the imino group, leaving a negative charge on 
the C2 atom and thereby forming the ylide (1).   
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Figure 1.2. Formation of the ThDP ylide. 
 
 
Once ThDP is activated, it can perform catalysis (Figure 1.3).  The 
nucleophilic C2 ylide attacks the carbonyl of a 2-keto acid substrate forming 2α-
lactyl-ThDP. This intermediate undergoes a rearrangement and, in the process, a 
molecule of carbon dioxide is expelled forming the 2α-carbanion-enamine 
intermediate. The addition of a proton to the carbanion forms the 2α-
hydroxyethyl-ThDP.  After another proton abstraction, the intermediate 
undergoes further rearrangement causing release of the aldehyde and 
regeneration of the ylide (1).  
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Figure 1.3. The archetypal catalytic mechanism of ThDP-dependent enzymes. 
Figure adapted from reference (3).  
 
 
 The reactions described above apply to the decarboxylation process. 
However, an alternative reaction, the carboligation reaction, is also possible. In 
order for carboligation to occur, a second molecule, such as an aldehyde, ketone, 
or another molecule of 2-keto acid, is required. In the carboligation reaction, the 
enamine-carbanion performs a nucleophilic attack on the carbonyl of the second 
molecule to form the carboligation product (4). 
 Perhaps the most studied thiamin diphosphate-dependent enzyme is 
pyruvate decarboxylase. This enzyme will be a major focus of this thesis.  
 
5 
 
5
 
1.2 Pyruvate decarboxylase, a modern ThDP-dependent enzyme 
Pyruvate decarboxylase (PDC) (EC 4.1.1.1) is a thiamin diphosphate 
(ThDP)-dependent enzyme that catalyzes the conversion of pyruvate to 
acetaldehyde and carbon dioxide. One of the best characterized PDCs is that 
from baker's yeast, Saccharomyces cerevisiae (ScPDC), which is often labeled as 
the “archetypal” ThDP-dependent enzyme.  
 
Figure 1.4. Monomer of PDC illustrating the layout of the individual domains, 
PYR domain (red), TH3 domain (yellow), and PP domain (blue). 
 
 
PDC consists of four identical monomers of 563 amino acids. Each 
monomer comprises three domains (Figure 1.4), namely the N-terminal or PYR 
domain that binds the pyrimidine ring of ThDP, the C-terminal or PP domain that 
binds the diphosphate group of ThDP, and the middle or TH3 domain that is 
believed to be involved in controlling the conformational equilibrium between 
the open and closed state of the enzyme (5-7). These monomers are further 
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organized into a tetramer. In the case of ScPDC, the minimal functional unit is a 
dimer. Based on this, the biological assembly is often described as a “dimer of 
dimers” (Figure 1.5) (8,9).   
 
 
Figure 1.5. Illustration of the PDC tetramer highlighting the individual 
monomers and the dimer of dimers.  
 
 
In any ThDP-dependent enzyme, the minimal functional unit must be a 
dimer because the ThDP binding site and the active site are located at the 
interface between the monomers. Figure 1.6 shows how ThDP is bound to the 
enzyme; the PYR domain of one monomer of the dimer is binding the pyrimidine 
ring while the PP domain of the other monomer binds the diphosphate moiety. 
This binding symmetry also indicates that there are two ThDP binding sites per 
dimer and four total in the tetramer (10).  
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Figure 1.6. ThDP (green and orange) bound at the interface between the 
monomers. The PYR domain of one monomer (cyan) binds the pyrimidine ring 
(green) of ThDP while the PP domain of the other monomer (magenta) binds the 
diphosphate moiety (orange) of ThDP. Figure prepared using PyMOL using data 
from PDB 1PVD. 
 
 
1.2.1 The ThDP binding site 
 A closer look into the ThDP binding site (Figure 1.7) reveals that the 
diphosphate group is complexed with Mg2+ as well as being stabilized via 
hydrogen bonding to the protein. It is worth noting Asp444 and Asn471; these 
residues are part of an amino acid sequence, GDGX24-27NN, which has been 
identified as the ThDP-binding motif and is conserved throughout all ThDP-
dependent enzymes (11).  Another important feature of ThDP is the 
conformation it takes within the enzyme, known as the “V” conformation. This 
conformation is necessary for catalysis because it allows the 4’ amino group to 
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be within interaction distance of the C2 reaction center (10). This conformation 
is seen only when ThDP is bound to the enzyme and has not been observed in 
free solution (1). In PDC, Ile415 stabilizes this conformation and mutations to 
this residue significantly affect catalysis (discussed further in Chapter 4) (12). 
The apparent need for a bulky hydrophobic residue to maintain this 
conformation is conserved throughout the ThDP-dependent enzyme family (13). 
 
Figure 1.7. Diagram of the residues lining the ThDP binding site as well as 
residues involved in catalysis. Residues numbered higher than 360 belong to the 
PP domain of one monomer (magenta), while residues number less then 187 
belong to the PYR domain of the other (cyan). Note the position of Ile415 and the 
V-conformation of the ThDP. Figure prepared using PyMOL using data from PDB 
1PVD. 
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1.2.2 The active site 
 Like the ThDP-binding site, the active site (Figure 1.8) is also situated at 
the monomer/monomer interface. In PDC, there are several residues that play 
an important role in catalysis and stabilization of the substrate. These residues 
provide the ideal environment for the reaction in Figure 1.3 to take place.  
 
Figure 1.8. Active site of PDC highlighting the catalytic acid/base residues. The 
residues in magenta are from one monomer while those in cyan are from the 
other. Figure prepared using PyMOL using data from PDB 1PVD. 
 
 
The residues that are within van der Waals radii distance of the methyl 
group of pyruvate include Phe292, Thr388, Ile 476, and Ile 480 (not pictured).  It 
is likely that these residues form a hydrophobic pocket around the methyl group 
of pyruvate and help to position the substrate for catalysis (4). The residues 
potentially interacting with the glyoxylate moiety include His114, His115, Asp 
28, and Glu477 (Figure 1.8). Mutation of these residues has revealed various 
10 
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negative effects on kcat, rather than Km. This suggests that these residues are 
involved in catalysis and are not present solely for the purpose of stabilizing and 
positioning the substrate (14,15). Many of the ThDP-dependent enzymes 
possess residues that occupy similar space too those in PDC. However, the 
overall conservation in the active sites of ThDP-dependent enzymes is very low 
(4,16). 
 
1.2.3 The regulatory site 
 ScPDC is allosterically activated and therefore possesses a separate 
regulatory binding site (Figure 1.9). This binding site is not found in most other 
ThDP-dependent enzymes including PDCs from bacteria.  
 
Figure 1.9. Regulatory binding site of PDC showing residues within 5 Å of 
pyruvate with Cys221 directly interacting with the substrate forming the 
thiohemiketal. Image prepared using PyMOL using data from PBD 2VK1. 
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The regulatory site is predominantly lined with positively charged side 
chains and it is thought that this feature helps to guide the activator molecule 
into the regulatory site (9).  Baburina et al. (17) determined that Cys221 is the 
site at which substrate activation is triggered. Three residues, His92, His225, and 
His310 line the regulatory site and promote the formation of a thiohemiketal. 
This results in a conformational change around the regulatory site that leads to 
the restructuring of several loops in the TH3 and PYR domains. As this occurs, 
the C-terminal helix closes over the active site (18). The restructuring causes 
His114, His115, and Asp28 to shift and rotate so that the substrate can interact 
with the C2 ylide. Interestingly, all side chains that form the active site, with the 
exception of His114, His115, and Asp28, remain unaffected by the binding of the 
substrate molecule to the regulatory site (9,18).  
 Although ScPDC possesses this extra binding site, it still shares many 
similarities with other ThDP-dependent enzymes. Given the diversity this 
superfamily possesses, these similarities suggest an evolutionary relationship.  
 
1.3 Evolutionary aspects of ThDP-dependent enzymes 
 ThDP-dependent enzymes catalyze a wide range of reactions including 
the oxidative and nonoxidative decarboxylation of 2-keto acids, carboligation 
reactions, the cleavage of C-C bonds, and the formation of C-S, C-N, and C-O 
bonds (Figure 1.10). As knowledge about ThDP-dependent enzymes 
accumulates, it has been found that the variety of reactions catalyzed is 
increasing while the extent of amino acid similarity is decreasing. In spite of this 
12 
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catalytic diversity, the three-dimensional structure of these enzymes remains 
effectively conserved (19). It is not surprising that with this influx of new 
information, the evolutionary history of this superfamily of enzymes is under 
investigation to determine how the family has evolved to catalyze so many types 
of reactions while still utilizing the same cofactor and same intermediate.  
 
Figure 1.10. The many types of reactions that can be catalyzed utilizing ThDP as 
a cofactor. Note: all reactions go through the same enamine-carbanion 
intermediate. Figure from reference (19). 
 
 
 Costelloe et al. (20) and Duggleby (6) have performed two separate 
analyses in which the amino acid sequences and the crystallographic structures 
of many ThDP-dependent enzymes, respectively, were compared. The common 
feature of all ThDP-dependent enzymes is the binding of ThDP at the interface of 
a conserved pyrimidine (PYR) binding domain and a diphosphate (PP) binding 
domain (20). Based on sequence alignments of the domains, ThDP-dependent 
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enzymes can be grouped into six main groups (Figure 1.11). These groups 
include the transketolase (TK)-like family, the 2-oxoisovalerate dehydrogenase 
(2OXO)-like family, the pyruvate ferredoxin reductase (PFRD)-like family, the 
sulfopyruvate decarboxylase (SPDC)-like family, the phosphonopyruvate 
decarboxylase (PhPyrDC)-like family, and the pyruvate decarboxylase (PDC)-like 
family, which is the largest family and the primary focus of this thesis (6,20).  
 
Figure 1.11. The domain arrangements of the six main families of ThDP-
dependent enzymes. Adapted from reference (20). 
 
 
 As mentioned previously, enzymes in the PDC-like family consist of three 
domains: the PYR domain, the PP domain, and the TH3 domain. Each of these 
domains contain a central, five or six-stranded, parallel β-sheet linked by α 
helices and connecting loops. Structural alignments of these domains (Figure 
1.12) demonstrate a high similarity in structure for the PP and PYR domains, 
suggesting that there is a common origin. The core structure of these two 
domains is highly conserved across the families (6).  
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Figure 1.12. Topology cartoon of the three domains of benzoylformate 
decarboxylase (BFDC) highlighting the structural similarities. Figure from 
reference (6). 
 
 
The common ancestor protein would most likely have possessed binding 
sites for both the pyrimidine ring and the diphosphate moiety, requiring a dimer 
to form in order for catalysis to occur. Today, the enzyme that most resembles 
this ancestor is sulfopyruvate decarboxylase, which consists of two single chains 
that come together to form the active site. The next logical step in the evolution 
process would be for these two separate chains to fuse into a single protein. 
Phosphonopyruvate decarboxylase is the modern enzyme that fits this 
description (6,20).  
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After the fusion into a single protein, it is probable that the TH3 domain 
was then also fused to the PYR and PP domains, forming the family of PDC-like 
enzymes. The TH3 domain is believed to be responsible for the binding of 
additional cofactors such as NAD+/NADH or FAD (1). While the TH3 domain in 
some enzymes, such as acetohydroxyacid synthase (AHAS) and pyruvate oxidase 
(POX), retains this function, in others, such as PDC, this function has been lost, 
thereby contributing to further diversity within this group of PDC-like enzymes 
(6). Based on Figure 1.11, it is clear that all members of the ThDP-dependent 
enzyme superfamily possess the PYR and PP binding domains but differ in the 
extra domains that have fused over time, giving this superfamily of enzymes 
such a diverse range of reactions while maintaining some structural and 
sequential similarity.  For example, PDC, AHAS, acetolactate synthase (ALS), POX, 
the pyruvate dehydrogenase complex (PDH), pyruvate ferredoxin 
oxidoreductase (PFRD), and 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) 
all utilize pyruvate as a substrate. However, these six enzymes fall into four 
different groups that pass through the same intermediate to yield six different 
products. This example further highlights the complexity and diversity of this 
enzyme superfamily.  
 
1.4 Research covered in this work 
 The research covered in this thesis maintains the theme of studying 
different evolutionary aspects of ThDP-dependent decarboxylases. In Chapter 3, 
the activity of phosphonopyruvate decarboxylase, a primitive member of the 
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ThDP-dependent enzyme superfamily, is examined. Chapter 4 covers the 
investigation of the potential isozymes of pyruvate decarboxylase from 
Saccharomyces cerevisae. Finally, in Chapter 5, an alternative selection method is 
investigated for site-saturation mutagenesis to carry out directed evolution of 
ThDP-dependent decarboxylases.   
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CHAPTER 2. MATERIALS AND METHODS 
 
 
 
2.1 Materials 
 Primers were synthesized by Integrated DNA Technologies (Coralville, 
IA) and were designed to use the QuikChange protocol from Agilent 
Technologies (Santa Clara, CA). Pfu Ultra was purchased from Stratagene (La 
Jolla, CA). Restriction enzymes were purchased from New England BioLabs 
(Ipswich, MA) and Thermo Fisher Scientific (Waltham, MA). The Champion 
pETSUMO expression system was purchased from Life Technologies (Grand 
Island, NY). DNA isolation from E. coli was performed utilizing the Zyppy 
Plasmid Miniprep Kit from Zymo Research (Irvine, CA) or the AxyPrep Plasmid 
Midiprep Kit from Corning (Tewksbury, MA). Sequencing was carried out at the 
University of Michigan DNA Sequencing Core Facility (Ann Arbor, MI). YEP broth, 
YEP agar, and SD Medium-URA were purchased from MP Biomedicals (Santa 
Ana, CA). DifcoTM YPD broth, YPD agar, Luria-Bertani (LB) broth, and LB agar 
were purchased from Becton, Dickinson and Company (Sparks, MD). Knockout 
yeast strains were provided by Prof. Jack Pronk (Delft University of Technology, 
Netherlands) and Prof. Stefan Hohmann (University of Gothenburg, Sweden). 
Nickel-nitrilotriacetic acid (Ni-NTA) resin was purchased from Qiagen (Valencia 
CA). A plasmid containing the recombinant alcohol dehydrogenase from Equus
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caballus was from Prof. Bryce Plapp (University of Iowa, Iowa City, IA) and the 
pET17HLADH-His plasmid was constructed by Dr. Malea M. Kneen (Indiana 
University-Purdue University Indianapolis, IN). IPTG, lysozyme, DNaseI, NADH, 
yeast alcohol dehydrogenase (YADH), and 2-keto acids were purchased from 
Sigma-Aldrich (St. Louis, MO). Buffers and other reagents were purchased from 
Sigma-Aldrich or Fisher Scientific (Pittsburgh, PA). Phosphonopyruvate, 
difluorophosphonopyruvate, and phosphonoacetaldehyde were synthesized by 
Katharina Pallitsch in the laboratory of Friedrich Hammerschmidt (University of 
Vienna, Austria). Hampton crystallization screening kit 1 and 2, crystal trays, and 
cover slips were purchased from Hampton Research (Aliso Viejo, CA). Wizard 
Classic Screening kits 1-4 were purchased from Rigaku Reagents (Bainbridge 
Island, WA). Homology models were constructed using the Phyre2 Protein Fold 
Recognition Server (21). Images were made using PyMOL (The PyMOL 
Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.). 
 
2.2 Transformations 
2.2.1 Escherichia coli transformation 
E. coli transformations were performed using TOP10 or BL21(DE3) 
chemically competent cells as required. Generally, a 50 μL aliquot of competent 
cells was allowed to thaw on ice. Once thawed, 5 μL of DNA was added to the 
cells and the mixture was kept on ice for 30 minutes. The mixture was heat 
shocked at 42 °C for 1 min 15 s and then cooled for 2 min on ice. LB media (250 
μL) was added to the mixture and the cells were allowed to shake (225 rpm) at 
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37 °C for 30-60 minutes. The cells (250 μL) were then spread onto LB plates 
containing the appropriate antibiotic. The plates were incubated overnight at 37 
°C. 
 
2.2.2 Saccharomyces cerevisiae transformation 
S. cerevisiae transformations were performed in the knockout strains 
listed in Table 2.1 using a modification of the Chen et al. protocol (22). 
Competent yeast cells were prepared at the time of transformation. The yeast 
strains were streaked from frozen stocks onto YEP plates containing 2% EtOH 
and were incubated at 30 °C for 3 days. A single large colony was selected and 
resuspended in 1 mL of One Step Transformation Buffer (0.2 M LiAc, 40% (w/v) 
PEG 4000, 100 mM DTT). This volume was sufficient for ten transformations. 
The transformation mixture contained 100 μL of cells, 50 – 1000 ng of 
transforming DNA, and ~15 μg of single stranded salmon sperm DNA (carrier 
DNA). The mixture was vortexed and incubated at 45 °C for 20 min followed by a 
30 min resting period on ice. The transformation was plated directly onto the 
appropriate selective plate and incubated at 30 °C for 3-4 days.  
 
Table 2.1. S. cerevisiae strains used in this study. 
 
Strain Genotype Source 
5.127-17C a leu2-3/112 ura3-52 trp1-92 pdc1D::LEU2 pdc5D::URA3 
pdc6D::TRP1 GAL  
(23) 
CEN.PK711-7C 
 
MATa ura3-52 pdc1Δ pdc5Δ pdc6Δ aro10::loxP-kan-loxP thi3::loxP-
kan-loxP  
(24) 
IMZ001 
 
MATa ura3-52 pdc1Δpdc5Δpdc6Δaro10::loxP-kan-loxP thi3::loxP-
kan-loxP p426GPD (URA3) 
 
(24) 
IMZ002 
 
MATa ura3-52 pdc1Δpdc5Δpdc6Δaro10::loxP-kan-loxP thi3::loxP-
kan-loxP pUDe001 (URA3TDH3pr-ARO10-CYC1ter)  
(24) 
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2.3 Construction of expression vectors 
2.3.1 Cloning and construction of expression vectors pET17PDC5-His, 
pET17PDC6-His, and pET17THI3-His 
 
 Dr. Malea M. Kneen completed the cloning and amplification of the 
ScPDC5, ScPDC6, and ScTHI3 genes into the pCRBLUNT vector. These plasmids, 
pCRBLUNT-PDC5, pCRBLUNT-PDC6, and pCRBLUNT-THI3, were digested with 
NdeI/XhoI and ligated into a pET17b vector, also digested with NdeI and XhoI. 
These ligations provided the expression vectors pET17PDC5-His, pET17PDC6-
His, and pET17THI3-His.  
 
2.3.2 Construction of a zeocin yeast expression vectors 
 The p426GPD-Zeo expression vector was constructed via the digestion of 
the zeocin cassette vector, pTEF1/Zeo (Life Technologies) and p426GPD high 
expression yeast shuttle vector (25). The p426GPD expression vector first 
underwent PCR mutagenesis to introduce the SphI restriction site using the 
primers listed in Table 2.2 and the parameters listed in Table 2.3 and Table 2.4. 
This resulted in a plasmid called p426GPD-SphI. The p426GPD-SphI vector was 
digested with SphI/ApaI and ligated with pTEF1/Zeo, also digested with 
SphI/ApaI. This digestion and ligation resulted in a plasmid called p426GPD-Zeo.  
The p426GPD-Zeo expression vector was digested with BamHI and religated. 
This removed one BamHI site and one EcoRI site to form the plasmid p426GPD-
Zeo-BamHI. PCR mutagenesis was also done on the p426GPD-Zeo-BamHI 
expression vector to introduce a HindIII restriction site (Table 2.2) resulting in 
the p426GPD-Zeo-HindIII plasmid.   
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Table 2.2. Forward primers used to introduce new restriction sites. 
Complimentary primers were synthesized based on the forward sequence.  
 
Primer Sequence 
p426GPD-SphI 5’-GTAAATGCATGCATACTAAACTCACAAATTAGAGC 
p426GPD-Zeo-HindIII 5’- ACCTTGCTTGAGAAGCTTTTGGGACGCTCGAAGGC 
 
 
 
Table 2.3. Site-directed mutagenesis reaction mixture. 
 
Amount Component 
5 μL 
10X Ultra AD Reaction Buffer: 100 mM KCl, 100 mM 
(NH4)2SO4, 200 mM Tris-HCl, 200 mM MgSO4, 1% Triton X-
100, 1 mg/ml BSA 
1.5 μL dNTP mix (40 mM) 
125 ng Forward oligonucleotide primer 
125 ng Reverse oligonucleotide primer 
50 ng or 200 ng Template DNA 
Up to 50 μL ddH2O 
1 μL Pfu Ultra High Fidelity DNA Polymerase (2.5 U mL-1) 
 
 
 
Table 2.4. Site-directed mutagenesis temperature cycling parameters. Over the 
first five cycles, the annealing temperature increases from 45 ˚C to 55 ˚C in 2 ˚C 
increments. 
 
Cycles Temperature (˚C) Time (s) 
Initial Denaturing 95 120 
1-5 
95 30 
45 30 
72 360 
6-25 
95 30 
55 30 
72 360 
Final Extension 72 600 
Hold 4 ∞ 
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2.3.3 Insertion of genes into zeocin yeast expression vector 
 The genes listed in Table 2.5 were inserted into the zeocin yeast 
expression vector using the restriction enzymes listed. Figure 2.1 provides a 
vector map illustrating where the genes were inserted.  
 
Table 2.5. The zeocin yeast expression vector with gene inserts and the 
restriction enzymes used. 
 
p426GPD-Zeo Expression Vectors Restriction Enzymes  
p426GPD-Zeo-PDC1-His BamHI/MluI 
p426GPD-Zeo-BFDC-His BamHI/HindIII 
p426GPD-Zeo-PDC5-His NdeI/XhoI (into p426GPD-Zeo-PDC1-
His) 
p426GPD-Zeo-ZmPDC BamHI/EcoRI 
p426GPDBDFC-Zeo-A460YT377L-
His 
BamHI/HindIII 
 
 
 
Figure 2.1. The p426GPD-Zeo plasmid map indicating the location of the 
restriction enzyme sites. The red arrow represents the GPD promoter.  
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2.4 Protein expression and purification of His-tagged enzymes 
2.4.1 Expression of His-tagged enzymes 
The expression of all proteins was carried out in BL21 (DE3) competent 
cells. The starter cultures (50 mL for a 1 L culture) for the expression of PDC1 
and PDC5 were grown overnight at room temperature while the starter cultures 
for all other proteins were grown at 37 °C. The 1 L cell cultures were allowed to 
grow at 37 °C until an OD600 of 0.6-0.8 was reached, at which point the cultures 
were chilled on ice for 10 min. Expression was induced by the addition IPTG to a 
final concentration of 1 mM. The cultures were chilled on ice for an additional 10 
min. The cell cultures were grown at room temperature overnight (18-20 h) 
with shaking at 225 rpm.  
The cells were harvested by centrifugation at 4 °C and the cell pellet was 
resuspended in 30 mL of Buffer 1 (50 mM NaPO4, 300 mM NaCl, and 5 mM 
imidazole, pH 8.0).  The cells were stored at -80 °C until required.  
 
2.4.2 General purification of His-tagged proteins 
Cells were thawed and lysozyme (200 μg/mL) and DNaseI (5 μg/mL) 
were added. The cells were incubated on ice for 30 minutes. For PDC1 and PDC5, 
PMSF (1 mM) was also added. Cell lysis was completed by sonication (2 x 90 s 
burst at 30% duty cycle with 90 s of rest between bursts). The resulting 
suspension was centrifuged twice for 30 min at 20,000 × g to remove all cell 
debris.   
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The cell free extract was loaded onto an Ni-NTA column (1.0×10 cm) 
previously equilibrated with Buffer 1 using a Biologic LC system (Bio-Rad, 
Hercules, CA). After loading, the column was washed with 20 column volumes of 
Buffer 1 and 8 column volumes of Buffer 2 (50 mM NaPO4, 300 mM NaCl, and 20 
mM imidazole, pH 8.0). Protein was eluted with 8 column volumes of Buffer 3 
(50 mM NaPO4, 300 mM NaCl, and 250 mM imidazole, pH 8.0) and fractions (5 
mL) were collected.  
The fractions containing protein were analyzed by SDS-PAGE to 
determine which fractions contained the desired protein and to assess the level 
of purity. The cleanest fractions were pooled and concentrated to 3 mL (Amicon 
Ultra, Millipore, Billerica, MA). The protein was desalted and the buffer 
exchanged to a storage buffer using an Econo-Pac DG10 desalting column (Bio-
Rad) that had been previously equilibrated with the appropriate buffer. 
Generally, the storage buffer contained 100 mM KPO4, 1 mM MgSO4, 0.5 mM 
ThDP, pH 6.0, and 10% (v/v) glycerol. Protein concentrations were determined 
from the absorbance at 280 nm using the molar extinction coefficients listed in 
Table 2.6. Concentrations were confirmed by Bradford assay using BSA as the 
protein standard (26). Proteins were stored at -80 °C. 
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Table 2.6. Molar extinction coefficients used in calculating protein 
concentration calculated using Northwestern University’s Peptide Calculator 
1.00 (http://www.basic.northwestern.edu/biotools/proteincalc.html, accessed 
February 15, 2015).  
 
Protein Extinction Coefficient (M-1 cm-1) 
PDC1 62070 
PDC5 63350 
BDFC-A460YT377L 61030 
PhPyrDC 21650 
Phtase 33240 
 
 
2.4.3 Purification of phosphonopyruvate decarboxylase and 
phosphonoacetaldehyde hydrolase 
 
 The plasmid containing recombinant phosphonopyruvate decarboxylase 
(PhPyrDC) from Bacteroides fragilis was a gift of Dr. Debra Dunaway-Mariano 
(University of New Mexico, Albuquerque, NM) and the pET24PhPyrDC-His 
plasmid was constructed by Dr. Forest H. Andrews (University of Colorado 
Denver, CO). The plasmid (pET22Phtase-His) containing a recombinant 
phosphonoacetaldehyde hydrolase (Phtase) from Pseudomonas putida was a gift 
of Dr. Georg A. Sprenger (University of Stuttgart, Germany).  Each of these 
proteins were expressed and purified as previously described except the storage 
buffer contained 50 mM HEPES, 300 mM NaCl, 10 mM MgCl2, and 1 mM DTT. 
PhPyrDC was stored at -80 °C while Phtase was stored at 4°C. 
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2.5 Protein crystallization 
2.5.1 Protein expression and purification for crystallization 
For crystallization, proteins were expressed and purified in the manner 
previously described. Proteins were concentrated and the elution buffer (Buffer 
3) was exchanged for crystallization buffer (25 mM HEPES, pH 7.0, 0.2 mM 
ThDP, 0.1 mM MgCl2) using an Econo-Pac DG10 desalting column equilibrated 
with crystallization buffer. The storage buffer for PhPyrDC contains HEPES so it 
was purified for crystallization in the same manner as a general purification.  
 
2.5.2 Crystallization of PDC5 
 PDC5 was concentrated to 15 mg/mL and crystals were grown using the 
hanging drop diffusion method. The wells contained 200 μL of 2 M ammonium 
sulfate and 100 mM sodium citrate/citric acid, pH 5.5. The drop mixture 
contained equal volumes of protein and well solution and was mixed on the 
cover slide. The crystals were grown at 4 °C. A white precipitate formed 
overnight and visible crystals appeared within 1-2 days. The crystals were 
transferred to a cryogenic solution of well buffer mixed with 15% (v/v) glycerol. 
The crystals were mounted on Hampton CryoLoops and flash frozen in liquid 
nitrogen.  
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2.6 Characterization studies 
2.6.1 Kinetic characterization of PDC1 and PDC5 
The activity of purified PDC1 and PDC5 was determined using a coupled 
assay. The assay mixture contained, in a total of 1 mL, 50 mM MES (pH 6.0), 2 
mM MgCl2, 1 mM ThDP, 0.2 mM NADH, 60 U/mL YADH or 0.25 U/mL HLADH 
(YADH for straight chain aliphatic substrates), and varying concentrations of the 
2-keto acid.  In some cases, the MES buffer was replaced by a phosphate buffer 
(100 mM KPO4 pH 6.0, 1 mM MgCl2, 0.5 mM ThDP) or an imidazole buffer (40 
mM Imidazole-HCl pH 6.0, 2 mM MgCl2, 1 mM ThDP). The reaction was carried 
out at 30 °C and initiated by the addition of PDC1 or PDC5. The reaction was 
monitored by a decrease in absorbance at 340 nm. Each assay was performed in 
triplicate. The kinetic parameters were determined by fitting the initial rate data 
to the Hill equation (Equation 1) using the enzyme kinetics package from 
SigmaPlot 12.3.  
 
Equation 1:  
𝜈 =  
𝑉𝑚𝑎𝑥[𝑆]
𝑛
𝐾𝐻
𝑛 + [𝑆]𝑛
 
 
2.6.2 Kinetic characterization of the benzoylformate decarboxylase 
T377L_A460Y variant 
 
The activity of purified BFDC T377L-A460Y was determined using a 
coupled assay. The assay mixture contained, in a total of 1 mL, 100 mM KPO4 (pH 
6.0), 1 mM MgCl2, 0.5 mM ThDP, 0.2 mM NADH, 60 U/mL YADH or 0.25 U/mL 
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HLADH (YADH for straight chain aliphatic substrates), and varying 
concentrations of the 2-keto acid. The reaction was carried out at 30 °C and 
initiated by the addition of BFDC T377L-A460Y. The reaction was monitored by 
a decrease in absorbance at 340 nm. Each assay was performed in triplicate. The 
kinetic parameters were determined by fitting the initial rate data to the 
Michaelis-Menten equation (Equation 2) using the enzyme kinetics package from 
SigmaPlot 12.3.  
Equation 2:  
𝜈 =  
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑚 + [𝑆]
 
 
2.6.3 Steady state analysis of phosphonopyruvate decarboxylase 
The activity of purified PhPyrDC was determined using a coupled assay. 
The assay mixture contained, in a total of 1 mL, 100 mM HEPES (pH 7.0) 5 mM 
MgCl2, 0.2 mM NADH, 60 U/mL YADH, 100 μg phosphonoacetaldehyde 
hydrolase, and varying concentrations of phosphonopyruvate (0.5-15 μM). The 
reaction was carried out at 30 °C and initiated by the addition of PhPyrDC. Each 
assay was performed in triplicate. The kinetic parameters were determined by 
fitting the initial rate data to the Michaelis-Menten equation (Equation 2) using 
the enzyme kinetics package from SigmaPlot 12.3.  
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2.6.4 IC50 and Ki determination for difluorophosphonopyruvate 
PhPyrDC was assayed in the presence of difluorophosphonopyruvate 
(DFPP) to determine the IC50 of the inhibitor. The standard assay was used but 
the concentration of the substrate, phosphonopyruvate, was held constant at 3 
μM (Km) or at 30 μM (10×Km) while the inhibitor concentration was varied. The 
IC50 was determined by plotting the concentration of inhibitor (μM) against the 
percentage of activity remaining. The Ki was determined from the IC50 value 
using the Cheng-Prusoff equation (Equation 3).  
Equation 3: 
𝐾𝑖 =
𝐼𝐶50
1 +
[𝑆]
𝐾𝑚
 
 
 
2.6.5 Reaction of difluorophosphonopyruvate with PhPyrDC monitored by 
circular dichroism (CD) spectroscopy and UV-VIS spectroscopy 
 
PhPyrDC (~50 μM), in a 2 mL volume of PhPyrDC storage buffer, was 
titrated with DFPP at concentrations ranging from 0-50 μM. DFPP was 
introduced in 10 μL aliquots with each addition resulting in a 5 μM increase in 
inhibitor concentration. Spectra were obtained using a 1 cm path length cell. 
After the addition of each of the inhibitor aliquots, the solution was gently mixed 
and allowed to sit for 3 minutes at 25˚C. Initially, the reaction mixtures were 
monitored on a Cary 50 Bio UV-Vis spectrophotometer at 440 nm to ensure the 
reaction was complete. The reaction mixture was then scanned from 550 – 250 
nm. The A440 titration curves were constructed using SigmaPlot 12.3. 
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This same procedure was repeated using the Jasco J-810 CD 
spectropolarimeter. The reaction mixture was monitored at 440 nm on a UV-VIS 
spectrophotometer after each addition of inhibitor to ensure the reaction was 
complete. The mixture was then scanned from 550 - 250 nm on the CD 
spectropolarimeter. The data obtained for each inhibitor concentration was the 
average of five scans. The titration curves for the change in ellipticity at 440 nm 
were constructed using SigmaPlot 12.3. 
 
2.6.6 Fluoride ion analysis of the reaction of difluorophosphonopyruvate with 
PhPyrDC 
 
 The fluoride ions expected to be released upon reaction of DFPP with the 
ThDP of PhPyrDC were monitored using a fluoride ion-selective electrode. The 
samples contained PhPyrDC (~100 μM) and DFPP (0-75 μM) in a total volume of 
1 mL. In addition to samples containing enzyme, two controls were used. The 
first contained PhPyrDC buffer and water, and the second contained PhPyrDC 
buffer, 75 μM difluorophosphonopyruvate, and water. Both solutions had a total 
volume of 1 mL. The samples were prepared by gentle mixing and were 
incubated at room temperature for 30 min. The enzyme was removed from the 
samples using 10,000 kDa cut-off microspin columns (Microcon, Millipore).  
Total ionic strength adjustment buffer II solution (TISAB II) was added to the 
samples for a final volume of 2 mL. The fluoride ion concentration in each sample 
was determined. This analysis was carried out in the Lippert laboratory at the 
Indiana University School of Dentistry. 
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CHAPTER 3. INACTIVATION OF PHOSPHONOPYRUVATE DECARBOXYLASE 
FROM BACTEROIDES FRAGILIS BY DIFLUOROPHOSPHONOPYRUVATE 
 
 
 
3.1 Background 
Phosphonopyruvate decarboxylase (PhPyrDC) catalyzes the breakdown 
of phosphonopyruvate to phosphonoacetaldehyde and carbon dioxide (Figure 
3.1). As noted in the introduction, PhPyrDC is thought to closely resemble the 
fused domain common ancestor of all ThDP-dependent enzymes (6,20).  Despite 
its potential importance, PhPyrDC has not been well studied and only a few 
aspects have been investigated. To date, only the PhPyrDCs from Bacteroides 
fragilis (Bf) and Streptomyces viridochromogenes Tü494 (Sv) have been 
characterized (27,28). 
 
 
Figure 3.1. Reaction scheme of the conversion of phosphonopyruvate to 
phosphonoacetaldehyde and carbon dioxide catalyzed by phosphonopyruvate 
decarboxylase (PhPyrDC).  
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 BfPhPyrDC was the first to be characterized by Zhang et al. (28). Based on 
sequence analysis, the group determined the molecular weight of BfPhPyrDC to 
be ~40 kDa and confirmed this experimentally. Johnen et al. (27), whose studies 
focused on SvPhPyrDC, determined the molecular weight to be ~44 kDa. 
Interestingly, the oligomeric state of SvPhPyrDC was determined to be 
homodimeric while that of BfPhPyrDC was found to be homotrimeric (27,28). To 
date, no crystal structure of PhPyrDC has been solved.  
 Using sequence alignments, both groups compared PhPyrDC to variants 
from other organisms, as well as other ThDP-dependent enzymes, to determine 
which residues were conserved. The conserved active site glutamate residue 
(Chapter 1) is also found in PhPyrDCs from both organisms. Johnen et al. (27) 
carried out mutagenesis at this site (Glu 48) to confirm the residue’s importance 
in catalysis. They prepared the Glu48Gln variant and found that, while it 
expressed to the same extent as wild-type, it was devoid of activity. Not 
surprisingly, both PhPyrDCs possessed the ThDP binding motif (GDGX24-27NN) 
and mutagenesis was performed to confirm the essential nature of these 
residues (27,28).  Furthermore, all PhPyrDCs used in the sequence alignment by 
Johnen et al. (27) possessed a conserved serine residue at position 25 
(SvPhPyrDC numbering). In some ThDP-dependent enzymes, such as 
benzoylformate decarboxylase, there is a serine in this position while in 
enzymes such as pyruvate decarboxylase, it is an aspartate (16).  Johnen et al. 
(27) used mutagenesis to explore the function of this residue and determined 
that Ser25 is important in substrate binding. SvPhPyrDC also possesses the 
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characteristic HH-motif (His110 and His111) seen in PDC-like enzymes. 
Mutations to His110 resulted in a loss of activity, but changes to His111 had no 
significant influence on catalysis (27).  Johnen et al. (27) also determined that 
Asp297 played an important role in substrate binding.  
 Zhang et al. (28) also performed mutagenesis on BfPhPyrDC to confirm 
the residues important to catalysis and ThDP binding. However, they also 
determined the kinetics for pyruvate as a substrate in addition to 
phosphonopyruvate. For phosphonopyruvate, the Km was found to be 3.2 ± 0.2 
μM and the kcat to be 10.2 ± 0.3 s-1. Pyruvate was a slow substrate with a Km of 25 
mM and a kcat of 0.05 s-1. In addition, sulfopyruvate and phosphonoacetaldehyde 
were shown to be competitive inhibitors of BfPhPyrDC (28).  Given that (1) 
sulfopyruvate is structurally similar to phosphonopyruvate, (2) 
phosphonoacetaldehyde possesses the “phosphono” group but not the 
carboxylate moiety, and (3) the low activity with pyruvate, Zhang et al. (28) 
concluded that, rather than the carboxylate moiety, the “phosphono” group must 
be of primary significance in substrate binding (28).  
 While, sequence alignments have been helpful in identifying some 
important residues, a crystal structure will aid in obtaining a more complete 
picture of this enzyme. In addition, it will answer the question of the enzyme’s 
oligomeric state. Here, in order to further the understanding of this enzyme, 
PhPyrDC was characterized in the presence of a mechanism-based inhibitor. In 
addition, crystallization trials were carried out.  
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3.2 Results and Discussion 
3.2.1 Purification and kinetic characterization of PhPyrDC 
 PhPyrDC from Bacteroides fragilis was expressed and purified as 
described in section 2.4 using a plasmid that was a gift from Dr. Debra Dunaway-
Mariano (University of New Mexico). The steady state kinetics of BfPhPyrDC 
were determined using a modified coupled assay. In a traditional coupled assay 
for ThDP-dependent decarboxylases, once the aldehyde is released it becomes 
the substrate for a yeast alcohol dehydrogenase (YADH) that converts it to an 
alcohol with the concomitant oxidation of NADH.  The reaction is monitored by 
observing the conversion of NADH to NAD+, which results in a loss of absorbance 
at 340 nm. In the case of PhPyrDC, the aldehyde that is released, 
phosphonoacetaldehyde, is not a substrate for YADH and, in order for the 
reaction to continue, the phosphono group must be removed. 
Phosphonoacetaldehyde hydrolase (Phtase) removes that group so the coupled 
assay can continue (Figure 3.2).  Accordingly, Phtase was also expressed and 
affinity purified using a plasmid that was provided by Dr. Georg A. Sprenger 
(University of Stuttgart).  
 
Figure 3.2. Scheme of the coupled assay used to monitor the conversion of 
phosphonopyruvate to ethanol. 
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 PhPyrDC exhibited Michaelis-Menten type kinetics (Figure 3.3) with its 
natural substrate, phosphonopyruvate. PhPyrDC did not exhibit any allosteric 
activation like that seen with yeast PDC (29). The Km was determined to be 2.9 ± 
0.2 μM with a kcat value of 10.1 ± 0.3 s-1. This provides a kcat/Km of 3500 mM-1s-1. 
By comparison, yeast PDC has a kcat/Km value of 45 mM-1s-1, which is almost 80-
fold lower than that of PhPyrDC, and PDC from Zymomonas mobilis has a kcat/Km 
value of 440 mM-1s-1, which is 8-fold lower (4). In addition, pyruvate was also 
tested as a substrate but no activity was detected under the conditions of our 
assay. Overall, these values are in good agreement with those determined by 
Johnen et al. (27).  
 
Figure 3.3. Michaelis-Menten plot for the reaction of PhPyrDC with 
phosphonopyruvate.  
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3.2.2 Design and synthesis of difluorophosphonopyruvate 
 PhPyrDC has not been studied in depth and much of the information 
gathered about the enzyme is obtained by comparisons with other ThDP-
dependent decarboxylases. This includes a prediction of the enzyme’s catalytic 
mechanism. It would be reasonable to assume that the catalytic mechanism is 
similar to the mechanism in Figure 1.3 seen the introduction. It has been shown 
that fluoropyruvate can be broken down by pyruvate decarboxylase and that a 
fluoride ion is released along with the generation of acetyl-ThDP (30). With that 
knowledge, a mechanism-based inhibitor, difluorophosphonopyruvate (DFPP), 
was designed based on the mechanism in Figure 3.4. 
 
Figure 3.4. The proposed mechanism of action of difluorophosphonopyruvate.  
 
 
 The proposed mechanism of action of DFPP involves the initial binding of 
the inhibitor to ThDP. The decarboxylation step proceeds as normal and the 
resultant 2-carbanion undergoes rearrangement to lose a fluoride ion. 
However, unlike the fluoropyruvate reaction with PDC, there is another fluorine 
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attached to C2, making any further rearrangements very slow, and thereby 
rendering the enzyme effectively inactive.  
DFPP was synthesized using the scheme in Figure 3.5 by Katharina 
Pallitsch in the laboratory of Friedrich Hammerschmidt (University of Vienna).  
 
Figure 3.5. Scheme of difluorophosphonopyruvate synthesis (1) (31). 
 
 
To confirm this proposed mechanism, a series of experiments was carried 
out.  
 
3.2.3 IC50 and Ki determination for DFPP 
 In a control experiment, the inhibitor was tested against the two coupling 
enzymes, Phtase and YADH. It was determined that DFPP did not inhibit the 
activity of these enzymes. However, it quickly became apparent that DFPP was a 
good inhibitor of PhPyrDC.  
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Figure 3.6. The IC50 determination of DFPP at 3 μM and at 30 μM. The values 
used in this plot are the mean of 3 independent trials. The red data points 
represent values determined at 3 μM and the blue data points represent values 
determined at 30 μM.  
 
 
The IC50 of DFPP was determined using two concentrations of 
phosphonopyruvate, 3 μM (Km) and 30 μM (10×Km). The data from each of these 
concentrations was plotted (Figure 3.6) and the IC50 was determined for each 
condition based on the plot. Using the IC50 values, the average Ki was calculated 
to be 0.60 ± 0.05 μM. Clearly, this value indicates that DFPP is a potent inhibitor 
of PhPyrDC. However, questions still remain as to (i) whether the inhibitor is 
reversible and (ii) what is its mechanism of action.  
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3.2.4 Dilution studies of PhPyrDC with DFPP 
In order to address the question of the reversibility of the enzyme, a 
dilution study was performed. The enzyme-inhibitor mix was incubated at 30 °C 
and, at appropriate time intervals, a sample of the mix was diluted 1:100 into an 
assay mixture containing 30 μM phosphonopyruvate. Due to the efficiency of the 
DFPP as an inhibitor of PhPyrDC, the reaction during these dilution studies 
occurred too quickly to monitor a time course for inactivation. In fact, after 
incubation with the inhibitor, no activity was seen at any of the time points 
tested. This clearly indicates that the inhibitor does bind in an irreversible 
manner.  
 
3.2.5 Reaction of DFPP with PhPyrDC monitored by circular dichroism (CD) 
spectroscopy and UV-Vis spectroscopy  
 
 To begin to understand the mechanism of action of DFPP, PhPyrDC was 
titrated with varying concentrations of DFPP. This resulted in the appearance of 
a yellow color. Consequently, this titration was monitored via UV-Vis 
spectroscopy and it was found that the color change was reflected by an increase 
in absorbance at 440 nm (Figure 3.7). The intensity increased linearly until a 
plateau was reached (Figure 3.7 inset). The plateau occurred at approximately 
the same concentration as that of the enzyme, indicating that the enzyme was 
saturated with inhibitor. 
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Figure 3.7. The titration of PhPyrDC (~50 μM) with DFPP as followed by UV-Vis 
spectroscopy. The inset is the plot of A440 vs. [I].  
 
 
It has been shown that, on ThDP-dependent enzymes, ThDP and any of its 
derivatives are chiral (32,33). This means the DFPP titration could also be 
monitored by CD spectroscopy. The titration was therefore repeated, under 
conditions identical to those used in the UV experiments.  As can be seen in 
Figure 3.8, there is an increase in ellipticity at 440 nm that also correlates with 
the observed color change and UV-Vis data. Further, there is again evidence of 
saturation, consistent with the UV data. Finally there is an increase in ellipticity 
at ~310 nm. This is consistent with a change from the AP form of ThDP to the IP 
41 
 
4
1
 
form seen with ThDP-derived intermediates (32,33). These data too suggest that 
the enzyme concentration used in the experiment is ~32 M. 
 
 
Figure 3.8. The titration of PhPyrDC (~100 uM) with DFPP as followed by CD 
spectroscopy. Figure A shows the monitoring from 550-250 nm, while Figure B 
highlights the changes occurring at 440 nm.  
 
 
 CD spectroscopy has been performed on other ThDP-dependent enzymes 
in the presence of a variety of inhibitors (34). Based on those earlier spectra, the 
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increase in ellipticity observed at 440 nm is likely to involve charge transfer 
transitions, but the basis for those transitions is yet to be determined (34).  
 
3.2.6 Fluoride ion analysis of the reaction of DFPP with PhPyrDC 
 
The proposed mechanism of the inhibitor (Figure 3.4) requires the release of a 
fluoride ion. To test this hypothesis, a fluoride ion-selective probe was used to 
analyze the products of the enzyme-inhibitor titration. Four different 
concentrations of inhibitor were tested, as well as two controls, as described in 
section 2.6.6. For this analysis, each reaction mixture contained 100 μM 
PhPyrDC. Based on the inhibitor concentrations used and the proposed 
mechanism of the inhibitor, we would expect to see a linear relationship 
between the amount of inhibitor and the amount of fluoride ion released.  
 
Figure 3.9. Fluoride ion analysis of the titration of PhPyrDC (100 M) with 
DFPP. 
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  Looking at Figure 3.9, we see a linear relationship between 0-50 mM 
DFPP, followed by a tapering off at a DFPP concentration between 50 μM and 75 
μM. More likely this is an indication that the enzyme is saturated at around 65 
μM rather than 100 μM. In Figure 3.9, we see start to see a tapering off around 
65 μM and in the inset of Figure 3.7 the plateau begins at around 32 μM. Given 
that the enzyme concentration was doubled for the fluoride ion analysis, these 
UV and fluoride ion data are in good agreement. It certainly is possible that our 
calculated enzyme concentration is lower than the actual value, especially given 
that enzyme concentrations are calculated using the Bradford method.  
The other possibility of error in this series of experiments is that the 
concentration of DFPP is not perfectly calculated. Since DFPP was synthesized 
and titrated to the sodium salt, calculating the exact molar mass difficult. The 
concentration of inhibitor may well be higher than expected. 
Overall, based on the proposed mechanism of action of DFPP, we would 
expect to see a 1:1 ratio of fluoride ion to DFPP. Taking the concentration errors 
into account, this analysis confirms that a fluoride ion is being released and the 
data is a good indication that this reaction is indeed happening in a 1:1 ratio.  
 
3.2.7 Crystallization studies of PhPyrDC 
 Our laboratory has previously shown the ThDP-dependent enzymes will 
often crystalize when the cofactor has been irreversibly inactivated (35). Here, 
we have demonstrated that DFPP does, in fact, irreversibly bind ThDP. However, 
initial crystallization trials with and without this inhibitor were not successful.   
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3.3 Conclusions and Future Direction 
 We have shown that difluorophosphonopyruvate is a mechanism-based 
inhibitor of PhPyrDC. By our studies to prove this, we have also demonstrated 
that the mechanism of the inhibition strongly correlates with the catalytic 
mechanism of PhPyrDC that has been proposed based on comparisons with 
other ThDP-dependent enzymes. In the future, stopped-flow experiments as well 
as 19F NMR will be used to investigate the intermediates of the PhPyrDC 
reaction. In addition, more inhibitors will be synthesized for further 
crystallization trials of PhPyrDC. 
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CHAPTER 4. INVESTIGATION AND CHARACTERIZATION OF THE MINOR 
ISOZYMES OF PYRUVATE DECARBOXYLASE ISOLATED FROM BAKER’S YEAST 
 
 
 
4.1 Background 
 Glycolysis is the metabolic pathway utilized by most organisms to 
produce energy from the catabolism of glucose to form pyruvate. Once pyruvate 
has been formed, depending on the organism, there are three possible pathways 
for the breakdown of pyruvate: 1) aerobic oxidation where pyruvate is 
converted to acetyl-CoA, which then goes on to enter the citric acid cycle, 2) 
anaerobic homolactic fermentation to form lactate, or 3) anaerobic alcoholic 
fermentation, where ethanol and carbon dioxide are the final products (Figure 
4.1).  
 
Figure 4.1. Glycolysis flowchart showing the three possible paths for the 
breakdown of pyruvate including the necessary reactants and the final products.
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In Saccharomyces cerevisiae, also known as Baker’s yeast, alcoholic 
fermentation is the principal pathway for the breakdown of pyruvate (36). The 
first step in alcoholic fermentation is the nonoxidative decarboxylation of 
pyruvate to acetaldehyde and carbon dioxide catalyzed by pyruvate 
decarboxylase (EC 4.1.1.1). This is then followed by the breakdown of the 
resulting aldehyde by alcohol dehydrogenase (ADH) to form ethanol (Figure 
4.2).   
 
Figure 4.2. Reaction scheme of the conversion of pyruvate to ethanol utilizing 
pyruvate decarboxylase (PDC) and alcohol dehydrogenase (ADH). 
 
 
In S. cerevisiae, pyruvate decarboxylase isozyme 1 (PDC1) is the primary 
isozyme that is expressed but, S. cerevisiae also possesses homologs for three 
other potential pyruvate decarboxylase isozymes, PDC5, PDC6, and THI3 (37).  
These will be the subject of the chapter. 
 
4.1.1 PDC5 
 The first potential isozyme, PDC5, shares 88% sequence identity with 
PDC1.  It was discovered by happenstance when researchers deleted or replaced 
pdc1 and the resulting mutants were still able to ferment glucose, contrary to 
what the researchers predicted would happen (37,38).   Seeboth et al. (38) 
determined that, in wild-type cells, pdc5 is transcribed in a small amount or not 
O
O
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O
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PDC ADH
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at all. However, when pdc1 is knocked out, pdc5 is transcribed at the same level 
as pdc1 in wild-type cells (38).  It is unlikely that pdc1 would be completely 
knocked out under normal circumstances so researchers investigated the factors 
affecting the expression and regulation of pdc5 (39).  
 They confirmed that the expression of both PDC1 and PDC5 is controlled 
by an autoregulation mechanism (38,39).  Muller et al. (40) hypothesized that 
the deletion of pdc1 could lead to higher ThDP levels in the cell, and that those 
higher levels could contribute to the stimulation of pdc5. Surprisingly, they 
found that ThDP is involved in PDC5 expression but high levels of ThDP cause 
repression rather than stimulation. They also determined that ThDP levels only 
affect the expression of PDC5 and not that of PDC1 (40). Eberhardt et al. (41) 
have determined that the autoregulation is independent of both sugar 
catabolism and the catalytic activity of PDC1. This suggests that PDC1 possesses 
a property beyond catalysis that is necessary to mediate the autoregulation. 
Further investigation utilizing pdc1 mutants, which encoded a PDC1 that was 
catalytically inactive, showed that expression of PDC5 was still repressed, 
suggesting that these mutants were still active as regulatory proteins (41).  
Konig et al. (42) have shown that in PDC1, ThDP is necessary for the stability of 
the protein, and the binding of ThDP causes conformational changes in the 
structure of the enzyme for oligomerization purposes. Taken this information 
into account, Muller et al. (40) suggested that under ThDP limited conditions, 
ThDP does not bind to PDC1 and the active conformation does not form. This 
inactivated conformation may be the signal for the expression of PDC5 (40).  
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 To date, the expression of pdc5, and the factors that affect it, are the only 
aspects that have been studied for this particular isozyme. A rationale for the 
isozyme’s presence has been presented but not confirmed and the function of 
the enzyme has yet to be determined. To expand our knowledge of this isozyme, 
our laboratory has purified, characterized, and obtained an X-ray crystal 
structure of PDC5. 
 
4.1.2 PDC6 
 As discussed in the previous section, the deletion of pdc1 causes an 
enhancement in the expression of PDC5. PDC6 is another apparent isozyme of 
PDC1. However, when pdc1 and pdc5 were deleted, no detectable activity was 
found for PDC6 and the deletion yeast strain was unable to ferment glucose 
(23,39).   Generally, the expression of PDC6 is extremely low, but when strains 
are grown on a non-fermentable carbon source such as ethanol, expression 
increases (23,43).  Hohmann et al. (23) discovered that the level of PDC6 mRNA 
in the wild-type strain is increased in comparison to the pdc1 knockout when the 
cells are grown on ethanol. This finding suggested that the expression of PDC6 is 
somehow connected to, at least, the presence of pdc1. In a later study, Hohmann 
et al. (43) also determined that the codon usage for PDC6 is typical for a weakly 
expressed protein, and that the pattern of the codon usage suggested that PDC6 
had evolved to be a weakly expressed version of PDC1. These early findings 
provided limited information about PDC6 and none alluded to any possible 
reasoning for its presence. 
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 In more recent studies, it has been shown that physiological changes 
cause large and genome-wide modifications in the gene expression of bacteria, 
yeast, and other eukaryotes (44).  Gasch et al. (45) have determined that yeast 
cells have specific genomic “programs” that are utilized for each unique stress 
that the organism may encounter and those “programs” involve the alteration of 
thousands of genes. They believe that isozymes are involved in this response, 
hypothesizing that isozymes may possess different properties that make them 
more beneficial in a given situation (45).  Fauchon et al. (44) determined that 
this was indeed the case concerning PDC6. 
 In their study, Fauchon et al. (44) exposed yeast to cadmium and show 
that, in order for the yeast to survive, they must remove it. Therefore, they must 
synthesize glutathione, a sulfur-containing compound, which is used to 
sequester the cadmium. To achieve the amount of sulfur needed, the yeast 
modifies its genomic expression so that the only genes that are expressed are 
those that require a limited amount of sulfur (44). Fauchon et al. (44) have 
shown that in response to cadmium, there is increased expression of PDC6 
mRNA. At the same time, the expression of PDC1 mRNA is decreased. In a later 
study, it was also shown that PDC6 is expressed when sulfur is limited in the 
growth media, confirming the role of the expression of PDC6 as a response to 
sulfur limitation (46). 
 These findings have shed light on the potential role of PDC6. However, 
information about this enzyme is still very limited. Our laboratory has taken on 
the study of the purified enzyme in an attempt to characterize it.  
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4.1.3 THI3 
 In S. cerevisiae, ThDP is synthesized de novo, or external thiamin is 
converted to ThDP (47,48). The enzymes involved in synthesis and the 
transcription factors involved in the regulation of these pathways have been 
termed the THI regulatory system (49).  These THI genes are some of the most 
strongly expressed in yeast, and are controlled by the level of thiamin present 
with higher concentrations repressing expression (47). Nishimura et al. (50) 
identified thi3 as a positive regulatory gene. Mutations to this gene caused a loss 
of the yeast’s ability to transport thiamin, as well as preventing the expression of 
many of the other genes involved in the THI regulatory system (49,50).  
 The product of thi3, THI3, contains 609 amino acids and shares 52% 
sequence identity with PDC1. THI3 contains the amino acid sequence, GDGX24-
27NN, that has been identified as a ThDP-binding motif which is conserved 
throughout ThDP-dependent enzymes (11). Nosaka et al. (49) hypothesized that 
the presence of this motif would allow THI3 to sense the presence of ThDP in the 
cell and expression or repression would be adjusted accordingly. Using 
mutagenesis to disrupt the binding of ThDP, it was found that the THI3 mutants 
were unable to detect high levels of ThDP and downregulate the expression of 
the THI genes thus confirming the hypothesis (49). 
 Despite its apparent function, THI3 is not similar to any other known 
transcriptional activator (49). Taking into account its high sequence similarity 
with PDC1, our laboratory has started an investigation into whether THI3 has 
51 
 
5
1
 
the capability of performing as a pyruvate decarboxylase in addition to its 
potential role as a regulatory protein.  
 
4.2 Results and Discussion 
4.2.1 Analysis of PDC5 
4.2.1.1 Sequence alignments and homology model comparison of PDC5 and 
PDC1 
 
 PDC5 and PDC1 share the greatest sequence identity of the three 
potential isozymes at 88%. PDC5 retains all of the active site residues that have 
been determined as necessary for functioning (Figure 4.3). There are several 
stretches where the amino acid differences occur more heavily, for example, 
residues 340-360. However, these regions are not near to any of the active site 
residues.  
 
Figure 4.3. Clustal W (51) sequence alignment of PDC1 and PDC5. The yellow 
highlights indicate where the sequences differ. 
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Homology models, based on PDC1, were constructed using the Phyre2 
Protein Fold Recognition Server. For the comparison of PDC1 and PDC5, PDB ID 
2VK8 was used as the template. This comparison is shown in Figure 4.4. This 
figure clearly emphasizes the fact that the ThDP-binding site and the active 
(substrate-binding) sites of PDC1 and PDC5 are essentially identical. 
 
Figure 4.4. Homology model, constructed using Phyre2, highlighting the 
difference between PDC1 and PDC5. Red indicates differences on one monomer 
while green indicates areas of difference on the other monomer. The black 
circles highlight pyruvate in the regulatory site and ThDP. 
 
 
Table 4.1 provides a closer look at the residue differences between PDC1 
and PDC5 around the binding sites out to 20 Å. In fact, the first significant 
difference occurs around 8 Å from the ThDP binding site with the Asp472Asn 
change, which takes a negatively charged residue to a neutral residue. The next 
significant change is around 12 Å from the substrate binding site and 20Å from 
the ThDP site. The Glu551Lys mutation changes a negative charge to a positive 
charge. Also within that 12 Å area around the substrate binding site is the 
positive to neutral Lys554Gln alteration. These appear to be the only major 
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changes close to the active and ThDP binding sites. There are other changes 
further out as can be seen in Table 4.1 but, if there is any reduction in activity, 
residue changes closest to these sites should be investigated first. Right now, it is 
not clear what these changes mean but there is emerging evidence that changes 
in sites that are distant from the active site can have an affect on the overall 
activity of an enzyme (52). 
 
Table 4.1. Differences surrounding binding sites between PDC1 and PDC5 
(using PDC1 numbering). Determined by using homology models. 
 
 ThDP Regulatory Substrate 
6 Å No Differences Val 285 Ile No Differences 
8 Å Asp 472 Asn Cys 222 Ala No Differences 
12 Å 
Ser 408 Val Ser 251 Ala Ser 408 Val 
Thr 419 Val Met 314 Ile Glu 551 Lys 
Ile 538 Val Lys 554 Gln 
20 Å 
Lys 269 Arg Val 158 Thr Gly 406 Ala 
Asn 356 Thr Met 187 Leu Thr 419 Val 
Leu 365 Met Ser 196 Ala Leu 466 Ile 
Gln 373 His Lys 198 Ala Asp 472 Asn 
Val 383 Ile Ile 201 Val Lys 484 His 
Gly 406 Ala Asp 202 Arg Gln 486 Glu 
Thr 422 Leu Ile 204 Val 
Ile 538 Val 
Ala 426 Thr Leu 205 Val 
Leu 466 Ile Asp 208 Ile 
Lys 484 His Ile 235 Met 
Gln 486 Glu Ala 242 Val 
Ser 497 Ala Phe 243 Tyr 
Asp 519 Glu Val 329 Ala 
Glu 551 Lys Gly 406 Ala 
Lys 554 Gln Ser 408 Val 
Ile 37 Leu 
Ala 106 Ser Ala 106 Ser 
Phe 427 Met 
Lys 505 Arg 
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4.2.1.2 Expression and kinetic characterization of PDC5 
 PDC5 was expressed and purified as described in section 2.4 resulting in 
20 mg/L of protein. Once purified, the protein could be stored at -80 °C for 
several months without significant loss in activity. The purified enzyme was 
screened under steady-state conditions using the standard coupled assay system 
typically used for ThDP-dependent decarboxylases. This meant that in the initial 
assays for this enzyme, a phosphate buffer was utilized. It was immediately clear 
that PDC5 exhibited allosteric activation similar to PDC1 as evidenced by the 
sigmoidal curve in Figure 4.5.  
 
Figure 4.5. Michaelis-Menten plot for the reaction of PDC5 with pyruvate. Note 
the sigmoidal curvature not seen with enzymes displaying Michaelis-Menten 
kinetics. Inset is the plot of the PhPyrDC reaction with phosphonopyruvate for 
comparison.  This indicates that PDC5 was an allosteric enzyme and, accordingly, 
kinetic data were fitted using the Hill equation. 
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As seen in Table 4.2, PDC5 has a minimum level of activity with all the 
substrates tested except benzoylformate. Surprisingly, by comparison to the 
literature values for PDC1 with pyruvate (S05 = 1.8 mM, kcat = 38 s-1 (53)), the 
PDC5 S05 value is greatly increased while the kcat is significantly reduced. Given 
that PDC1 and PDC5 share 88% sequence identity and identical active sites, 
these numbers are surprisingly different. Upon further review of the literature, it 
was discovered that, unlike most ThDP-dependent enzymes, PDC is inhibited by 
phosphate. In fact, phosphate reduces the enzyme’s affinity for its substrate 
while also enhancing cooperativity (54). It is believed that this inhibition helps 
to regulate fermentation in addition to substrate activation (11).  
 
Table 4.2. Kinetic Characterization of PDC5 carried out in a phosphate buffera 
Substrate S05 (mM) kcat (s-1) kcat/ S05 (mM-1s-1) n Value 
Pyruvate 35 ± 4 10 ± 1 0.30 1.7 
2-Ketobutanoate 12± 1 5.3 ± 0.2 0.45 1.9 
2-Ketopentanoate 19 ± 1 4.6 ± 0.1 0.24 1.9 
2-Ketohexanoate 17 ± 1 2.0 ± 0.1 0.12 2.3 
3-Methyl-2-
ketobutanoate 
21 ± 1 2.1 ± 0.1 0.099 1.9 
4-Methyl-2-
ketopentanoate 
46 ± 5 1.7 ± 0.2 0.038 2.1 
4-Methylthiol-2-
ketobutanoate 
13 ± 1 0.88 ± 
0.07 
0.071 2.0 
Phenylpyruvate 
6.2 ± 0.9 0.57 ± 
0.09 
0.092 1.4 
Benzoylformate NADb NADb NADb NADb 
a Values are the mean of 3 independent determinations ± standard error 
b NAD: No activity detected 
 
b 
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Based on the literature, the most popular buffers for the assay of PDC 
were a MES buffer and an imidazole buffer (14,24). In light of this information, 
these buffers were investigated to determine which yielded the greatest activity.  
 
Table 4.3. Comparison of PDC1 and PDC5 in various buffers utilizing pyruvate 
as a substrate. 
 
Enzyme - Buffer S05 (mM) kcat (s-1) kcat/ S05 (mM-1s-1) n Value 
PDC1 - MES 1.3 ± 0.1 60 ± 2 45.3 2.1 
PDC1 - Imidazole 8.9 ± 0.7 74 ± 4 8.3 2.0 
PDC1- Phosphate 19 ± 3 66 ± 9 3.4 2.0 
PDC5 - MES 2.9 ± 0.1 64 ± 1 22.2 2.2 
PDC5 - Imidazole 12 ± 1 75 ± 3 6.1 2.3 
PDC5 - Phosphate 35 ± 4 10 ± 1 0.30 1.7 
 
From Table 4.3, it can be seen that PDC1 exhibited the lowest S05 in the 
MES buffer at 1.3 mM. In addition, PDC5 also exhibited the lowest S05 in the MES 
buffer at 2.9 mM. Looking at the kcat for PDC1 across the buffers tested, the value 
is slightly varied but largely unaffected. Interestingly, for PDC5, the phosphate 
buffer significantly decreases kcat. The cooperativity of both enzymes remains 
unaffected.  
 In reviewing the literature, it was noted that a full characterization of 
PDC1 with an array of 2-keto acids had not been completed. For purposes of 
comparison against PDC5, this characterization was carried out using the 
optimum MES buffer system. The data is shown in Table 4.4.  
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Table 4.4. Kinetic Characterization of PDC1 utilizing a MES bufffera 
Substrate S05 (mM) kcat (s-1) kcat/S05 (mM-1s-1) n Value 
Pyruvate 1.3 ± 0.1 60 ± 2 45 2.1 
2-Ketobutanoate 0.49 ± 0.02 25 ± 1 49 2.7 
2-Ketopentanoate 1.1 ± 0.1 27 ± 2 24 2.1 
2-Ketohexanoate 1.5 ± 0.1 15 ± 1 9.8 1.9 
3-Methyl-2-
ketobutanoate 
0.73 ± 0.03 6.3 ± 0.2 8.6 2.5 
3-Methyl-2-
ketopentanoate 
8.7 ± 0.5 22 ± 1 2.5 2.2 
4-Methyl-2-
ketopentanoate 
5.0 ± 0.2 10 ± 1 2.0 2.0 
4-Methylthiol-2-
ketobutanoate 
0.80 ± 0.05 5.2 ± 0.3 6.6 2.4 
Phenylpyruvate 0.23 ± 0.01 
0.87 ± 
0.02 
3.7 2.5 
Benzoylformate NADb NADb NADb NADb 
a Values are the mean of 3 independent determinations ± standard error 
bNAD: No activity detected 
 
PDC1 had the best kcat/S05 values for pyruvate and 2-ketobutanoate; these 
values are the same within error. Interestingly, PDC1 had a lower S05 value (2-
fold) for 2-ketobutanoate than for pyruvate but had a much higher kcat value for 
pyruvate. PDC1 had the lowest kcat/S05 value for 4-methyl-2-ketopentanoate 
while no activity was exhibited with benzoylformate.  
A similar kinetic characterization was carried out for PDC5, and the 
results shown in Table 4.5.  
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Table 4.5. Kinetic Characterization of PDC5 utilizing a MES buffera 
Substrate S05 (mM) kcat (s-1) kcat/ S05 (mM-1s-1) n Value 
Pyruvate 2.9 ± 0.1 64 ± 1 22 2.2 
2-Ketobutanoate 1.0 ± 0.1 43 ± 1 44 2.5 
2-Ketopentanoate 5.8 ± 0.3 24 ± 1 4.2 2.3 
2-Ketohexanoate 3.4 ± 0.1 15 ± 1 4.4 2.5 
3-Methyl-2-
ketobutanoate 
2.3 ± 0.1 13 ± 1 5.7 2.6 
3-Methyl-2-
ketopentanoate 
16 ± 1 26 ± 2 1.6 2.7 
4-Methyl-2-
ketopentanoate 
12 ± 1 12 ± 1 1.1 2.3 
4-Methylthiol-2-
ketobutanoate 
1.8 ± 0.1 6.8 ± 0.2 3.8 3.2 
Phenylpyruvate 0.5 ± 0.1 2.0 ± 0.1 4.2 2.4 
Benzoylformate NADb NADb NADb NADb 
a Values are the mean of 3 independent determinations ± standard error 
bNAD: No activity detected 
 
The data showed that 2-ketobutanoate had the best kcat/S05 value at 44 
mM-1s-1 with pyruvate following at 22 mM-1s-1. In almost all instances, within 
error, PDC1 had higher activity with the substrates tested. Intriguingly, with the 
exception of benzoylformate, both enzymes exhibited some level of activity with 
all substrates tested. Overall, the result of the comparison of these enzymes is 
not surprising. The high level of sequence identity and the suggested function of 
PDC5 as a “back-up” to PDC1 in certain circumstances would lead to the 
expectation that these enzymes would and should function in a similar manner 
for cell survival.  
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4.2.1.3 Crystallization, X-ray structure and structure analysis for PDC5 
 PDC5 was expressed and purified for crystallization as described in 
Chapter 2. The purified protein was concentrated to a final concentration of 15 
mg/mL. Seeding was used to facilitate crystal growth utilizing the hanging drop 
diffusion method. Screening kits from Hampton Research and Rigaku were used 
to test various potential crystallization conditions. Once the crystals began to 
appear, those conditions were tested with the crystallization buffer alone and 
with varying concentrations of enzyme to optimize the conditions and to help 
determine whether the observed crystals were salt or protein. 
Figure 4.6. Crystal of PDC5 that resulted in an X-ray structure. 
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Protein crystals were obtained using a 2 M ammonium sulfate and 100 
mM sodium citrate/citric acid, pH 5.5 solution and crystals formed in the 
absence of substrate or a substrate analog. These crystals were utilized for the x-
ray diffraction (Figure 4.6) and found to diffract to 2.8 Å. The relatively poor 
diffraction is likely due the crystal having two space groups for one crystal, also 
known as being twinned. Another possible cause for the poor diffraction is that 
the cryogenic conditions were not optimized, due to the limited number of 
crystals available. 
Dr. Forest H. Andrews completed the refined model. Refinement statistics 
can be seen in Table 4.6.  The best model resulted in an Rfree value around 40% 
and an Rwork of 33%.  
 
Table 4.6. X-ray diffraction data collection and refinement statistics 
 PDC5  
Data collection APS GM/CA-23-ID-B  
Space group   
Cell dimensions P212121  
    a, b, c (Å) 90.0, 90.0, 90.0  
 ()  114.0, 151.6, 194.8  
Resolution (Å) 2.78-18.0 (2.78-2.83)  
Rsym or Rmerge 15.6 (68.0)  
I/I 5.7 (2.5)  
Completeness (%) 98.8 (99.5)  
Redundancy   
   
Refinement   
Resolution (Å) 2.78  
No. reflections 340138  
Rwork/ Rfree 33.4/40.6  
No. atoms 17490  
    Protein 17208  
    Water 282  
B-factors 37.23  
R.m.s deviations   
    Bond lengths (Å)  0.010  
    Bond angles (º) 1.443  
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The active site of PDC5 was then compared to the active site of PDC1 in 
the open and closed conformations (PDB IDs 1PVD and 2W93, respectively).  As 
can be seen in Figure 4.7, the overlay of the active sites of these two enzymes in 
the open conformation is almost identical. This would be expected since PDC5 
was not crystalized with any substrate analogs. It is clear that Ile415, Glu51, 
His115, and Glu477 align almost perfectly, and that there is very little difference 
between the two structures. However, although Asp28 and His114 both occupy 
the same spatial area, these PDC5 residues appear to be different rotamers than 
those in PDC1. This is not uncommon and can often be seen between structures 
of the same enzyme. 
Figure 4.7. Comparison of the active sites of PDC1 (magenta) and PDC5 (cyan) 
in the open conformation from two views. Figures were generated using PyMOL 
with the PDC1 data from PDB ID 1PVD.  
 
 
The PDC5 structure was also compared with that of PDC1 in the closed 
conformation, (Figure 4.8).  Here, Ile415, and Glu51, and Glu477 (Gln477 in the 
PDC1 variant used) remain almost unchanged between the open (PDC5) and the 
closed (PDC1) conformations. However, looking at His114, His115, and Asp28, 
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there is a clear shift in the active site between PDC1 (closed conformation) and 
PDC5 (open conformation). The HH-motif appears to shift closer to the substrate 
while Asp28 moves over to accommodate the shifting histidine residues. This 
comparison is in good agreement with the restructuring that occurs when 
substrate binds to the regulatory site as described in the introduction. 
 
 
Figure 4.8. Comparison of the active sites of PDC1 (yellow) and PDC5 (cyan) 
using the closed conformation of PDC1 from two views. Figures were generated 
using PyMOL with data from PDB ID 2W93 used for PDC1. Note that, in order to 
generate the closed conformation, a PDC1 mutant, Glu477Gln in complex with 
pyruvamide was used.  
 
 
 
4.2.2 Analysis of PDC6 
4.2.2.1 Sequence alignment and homology model comparison of PDC6 and PDC1 
 PDC1 and PDC6 share 83% sequence identity and a purpose for this 
isozyme has been determined as a “sulfur-limited” response. In fact, PDC6 has 
substitutions for 11 of the 17 sulfur-containing residues within the sequence. 
The sequence alignment of these enzymes can be seen in Figure 4.9. 
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Figure 4.9. Clustal W sequence alignment of PDC1 and PDC6. The yellow 
highlights indicate amino acid changes from PDC1. In addition, those amino acids 
highlighted in green indicate where a sulfur-containing residue has been 
replaced.  
 
 
When comparing these sequences, it should be noted that PDC6 retains 
all the conserved acid/base residues shown in Figure 1.8. To enable further 
characterization, PDC6 was expressed and purified as described in section 2.4 
(see below for more detail). Unlike PDC5, the yield of enzyme was relatively poor 
and, more importantly, the purified enzyme was inactive. This leads to the 
question of what residue differences could lead to an inactive enzyme. Using a 
homology model, constructed using Phyre2 as described earlier, the structures 
of these enzymes were examined, paying particular attention to each of the 
binding sites: ThDP, regulatory, and substrate.  
Table 4.7 lists the differences found between the two enzymes around 
each of these binding sites out to a distance of 20 Å. Since the activity of the 
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enzyme is in question, it would make sense that residue changes closest to the 
substrate binding site or ThDP binding site are going to be the most important to 
look at.  
 
Table 4.7. Differences surrounding binding sites between PDC1 and PDC6 
(PDC1 numbering). The differences in sulfur-containing residues are in green.   
 ThDP Regulatory Substrate 
6 Å No Differences His 313 Tyr No Differences 
8 Å No Differences Cys 222 Ala No Differences 
Met 247 Leu 
12 Å 
Met 370 Leu Tyr 157 Phe Ile 71 Val 
Ala 386 Ser Val 158 Ile Ala 386 Ser 
Gln 486 Glu Ala 218 Ser Asn 548 Ser 
Gly 492 Thr Asp 226 Asn Val 550 Ile 
Ile 70 Leu Ile 306 Val Glu 551 Lys 
Ile 71 Val Met 314 Val 
Lys 554 Gln 
Ile 538 Leu Pro 322 Leu 
Met 539 Lys 
Val 329 Ala Gln 547 Glu 
Asn 548 Ser 
Val 550 Ile 
20 Å 
Met 247 Leu Met 67 Leu Val 22 Ile 
Gln 373 Glu Cys 152 Leu Cys 69 Val 
Gly 375 Ser Val 163 Ser Ile 70 Leu 
Val 384 Ile  Met 187 Leu Met 247 Leu 
Thr 399 Ile Ala 194 Pro Met 370 Leu 
Thr 404 Ala Ser 196 Ala Val 384 Ile 
Lys 484 His Ile 204 Val Lys 484 His 
Ser 497 Ala Asp 208 Val Gln 486 Glu 
Thr 501 Ala Ala 229 Lys Gly 492 Thr 
Arg 511 Lys Lys 232 Gln Ile 538 Leu 
Val 512 Ile Ile 316 Val Met 539 Lys 
Val 22 Ile Arg 317 Lys Gln 547 Glu 
Met 43 Leu Lys 332 Asn 
 
Cys 69 Val Val 384 Ile 
Ala 137 Ser Ala 386 Ser 
Val 163 Ser Thr 404 Ala 
Glu 551 Lys  
Lys 554 Gln 
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Interestingly, no differences occur until at least 12 Å from any of those 
sites. Perhaps the most interesting change is Glu551Lys, where a negative charge 
is substituted by a positive charge. This occurs around 12 Å from the substrate 
binding site and 20 Å from the ThDP binding site. Further out from these 
differences are changes where a neutral amino acid is replaced by a charged 
amino acid or vice versa, as is the case in Lys554Gln, Gln486Glu, and Gln547Glu. 
Not taking into consideration these changes, all other changes seem minor. 
However, it is possible that the sum of these changes is enough to result in the 
inactive enzyme that was produced in this study (see below). 
 
4.2.2.2 Expression conditions for PDC6 
 PDC6 was expressed using LB media and IPTG induction, however, the 
amount of protein obtained was <5 mg/L and the enzyme was virtually inactive. 
In an attempt to increase the yield of protein and possibly the activity of the 
enzyme, auto-induction media and terrific broth (TB) with IPTG induction were 
tried. The auto-induction media yielded similar amounts of inactive protein. 
Interestingly, when using the terrific broth, and growing the cultures from start 
to finish at room temperature, with the exception of the 2- 3 hours at 37 °C to 
reach an OD of 0.6, the amount of purified protein more than doubled reaching 
>10 mg/L.  
In this case, the enzyme remained inactive. However, it should be noted 
that the protein that is expressed is soluble and does not form inclusion bodies. 
This would indicate that, at the very least, the enzyme is folding in a somewhat 
66 
 
6
6
 
correct manner and is not likely the direct cause of inactivity.  More work is 
required to identify the problem so that characterization can be carried out. 
 
4.2.3 Analysis of THI3 
4.2.3.1 Sequence alignment and homology model comparison of THI3 and PDC1 
THI3 and PDC1 share 52% sequence identity (Figure 4.10), the lowest of 
the three potential isozymes. When comparing these sequences, THI3 maintains 
the conserved ThDP binding site, GDGX24-27NN, mentioned in the previous 
section. THI3 also possesses the essential glutamic acid residue (Glu51), the HH-
binding motif, and Cys221, the residue that is essential for regulation. However, 
THI3 differs from PDC1 in three important active site residues, i.e., 1) Asp28 has 
been replaced by Glu, 2) Ile415 has been replaced by Val, and 3) Glu477 has 
been replaced by Asp. 
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Figure 4.10. Clustal W sequence alignment of PDC1 and THI3. The yellow 
highlighting indicates the differences between the sequences. The purple 
highlights indicate the beginning and ending of the conserved ThDP binding 
sequence, GDGX24-27NN. The blue highlighting indicates changes in residues 
known to be critical for the functioning of PDC1. 
 
 
 Homology models based on PDC1 were constructed using Phyre2 Protein 
Fold Recognition Server. A comparison of the active site differences between 
PDC1 and THI3 (Figure 4.11) was prepared using PDB ID 2VK8 (PDC1) as the 
template. These models help to provide insight into how these changes may 
affect the positioning of the substrate and cofactor and also how catalytic ability 
may be affected. Figure 4.11A illustrates the change at position 415 (PDC1 
numbering) from an isoleucine in PDC1 to a valine in THI3. 
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Figure 4.11. Overlay of THI3 (cyan and yellow for each monomer) and PDC1 
(magenta). A) Ile415 replacement by Val, B) Asp28 replacement by Glu, C) 
Glu477 replacement by Asp. Figures constructed using PyMOL with data from 
PDB ID 2VK1 and 2W39. 
 
 
 
 
 
 
 
69 
 
6
9
 
In the introduction, it was noted that the V-conformation of ThDP is 
necessary for catalysis, and it was believed that this conformation was 
maintained by the presence of a bulky, hydrophobic residue (Ile415 in PDC1). 
Andrews et al. (13) recently showed that this is not the case in BFDC, and that 
the V-conformation seemed to be attained essentially independently. However, 
the identity of the residue at that position did play a large role in enzyme 
activity. Guo et al. (12) have studied this position extensively in PDC and found 
that mutations to this position have a large effect on catalytic activity. In fact, 
when the Ile415Val mutation was tested, it was found that kcat was significantly 
diminished with the mutant only retaining 6% of wild-type activity. Conversely, 
S0.5 was only slightly affected (12). This significant reduction in activity suggests 
that this I415V mutation may be one of the contributing factors to why THI3 
appears to be catalytically inactive. 
 Figures 4.11B and 4.11C illustrate the changes at position 28 from an 
aspartate in PDC1 to a glutamate in THI3, and at position 477 from a glutamate 
in PDC1 to an aspartate in THI3. In PDC1, Asp28 and Glu477 play pivotal roles in 
catalysis due to their ability to form hydrogen bonds with the carboxylate moiety 
of pyruvate and position the substrate. When these sites have undergone 
mutation, the resulting enzymes have been almost catalytically inactive (for 
D28A kcat = 0.07 s-1, for E377Q kcat = 0.09 s-1) (14,55,56). Presumably these 
changes would also render THI3 inactive.  
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4.2.3.2 Attempted expression of THI3 
 The expression of THI3 utilizing the pET17THI3-His plasmid was carried 
out as described in Chapter 2. In addition to using LB media with IPTG induction, 
expression was also attempted in an auto-induction medium, as well as terrific 
broth (TB) with IPTG induction. Expression cultures were grown at both 37 °C 
and at room temperature. However, no expression of the protein was seen under 
any of the conditions tested.  
 Under my supervision, a pETSUMO-THI3 expression vector was 
constructed by Ahmed Malik to determine whether use of a fusion protein (57) 
could help to facilitate the expression of THI3. However, when expression was 
reattempted, unfortunately, there was no evidence of protein expression.  
 Alternatively, the pKK223 is under a tac promoter system while the pET 
system uses a T7 promoter system. This difference in promoter systems was 
utilized to again attempt expression. Again, no expression was seen with the 
conditions tested.   
 
4.3 Conclusions and Future Directions 
We have fully characterized PDC5 and have confirmed its similarity to 
PDC1. However, the role of PDC5 as a “back-up” to PDC1 still remains to be 
proven.  We were unable to characterize PDC6 due to the inability to obtain 
active protein. It is possible, given the successful expression of active PDC6 in 
yeast (24), that E.coli is not a suitable model organism for the expression of 
active PDC6. In contrast, THI3 has not been expressed in E. coli. Nosaka et al. 
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(49) have reported some expression in yeast but these levels are negligible 
(~100 μg/L). Taking into account the three major residue differences between 
THI3 and PDC1 and our unsuccessful expression, our laboratory is currently 
making the necessary variants to determine whether expression and activity can 
be achieved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
72 
 
7
2
 
CHAPTER 5. INCREASING THE EFFICIENCY OF THE SCREENING AND 
SELECTION REQUIRED FOR SITE-SATURATION MUTAGENESIS OF PDC 
VARIANTS 
 
 
 
5.1 Background 
5.1.1 Site-saturation mutagenesis 
Directed evolution, a term used to describe a range of molecular biology 
techniques that allow natural evolutionary processes to be mimicked in the lab, 
has emerged as a useful way to engineer the catalytic properties of enzymes 
(58,59). These techniques include error-prone PCR (epPCR), DNA shuffling, and 
site-saturation mutagenesis. Error-prone PCR, the most frequently used 
technique, introduces random point mutations and is thought to address the 
gene as a whole (59,60). DNA shuffling allows random recombination between 
two or more genes and is often used in conjunction with epPCR (58,61). Site-
saturation mutagenesis (SSM) allows for an individual site to be targeted for 
mutagenesis wherein all 20 natural amino acids can be substituted into that site 
(62). This last technique gives the ability to generate protein variants that are 
novel, revealing functional capabilities of an enzyme that would not have been 
discovered based on using rational design alone. Based on this, SSM has been 
used to engineer changes in substrate specificity, enantiospecificity, to improve 
thermostability, and to introduce new enzyme functions (3). 
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To begin using SSM, degenerate mutagenic primers are designed. This 
means that the primers synthesized are a mixture of oligonucleotides that are 
identical except in the position that has been targeted for mutagenesis. The 
identical parts of the primers allow annealing to occur to the parental DNA while 
the degenerate position creates diversity in the amplified product (63). This 
amplified product is then transformed into E. coli or another model organism 
and a library is created and screened for activity.  Using this technique, two 
problems can arise. First, SSM can be experimentally time consuming because 
multiple rounds of mutagenesis are required to create variants that have been 
successfully evolved to perform the desired function. Second, the number of 
colonies that have to be screened to ensure that every amino acid has been 
covered at a site increases exponentially as each additional site is targeted. To 
address the first issue, the iterative saturation mutagenesis (ISM) and 
combinational active site saturation mutagenesis (CAST) techniques have been 
developed (64,65). In ISM, sites are chosen, generally based on structural data or 
homology models, and SSM is carried out on one site. Single SSM is carried out 
for each of the chosen spots. The multiple libraries generated are then screened 
and the mutants that are classified as “hits” are then put through another round 
of SSM at one of the next spots chosen. This cycle continues until the desired 
results are achieved (64). The CAST technique, on the other hand, targets 
multiple sites at one time (65). By combining one or both of these techniques 
with rational design, the experimental time can be reduced but these techniques 
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alone fail to address the fact that the genetic code is redundant and results in 
large numbers of colonies needing to be screened.  
The most important aspect of a SSM experiment has to deal with the 
codon randomness. A completely randomized codon results in a library size of 
64 different sequences that encode all 20 amino acids and 3 stop codons (63). 
This is also known as the NNN library where N can be adenine (A), cytosine (C), 
thymine (T), or guanine (G). Using the NNN library will result in 64 different 
combinations of nucleotides at a single selected position and, to ensure that full 
coverage is achieved, around 200 colonies will need to be screened (59). If the 
number of sites being targeted is increased to three, there are 262,144 different 
combinations possible, thus the requirement for colony screening increases 
exponentially (63). In order to reduce these numbers but still maintain full 
coverage of all the amino acids, the NNK library was developed where K is either 
a T or G. By eliminating some of the redundancy in the genetic code, the library 
size is reduced (59,63). For instance, in the NNN library, arginine has six codons 
that code for it but, in the NNK library, there are only two codons for arginine.  
Another library, the NDT library (where D can be A, G, or T), reduces the possible 
number of amino acids to 12 from the native 20. However, this library does 
include a balanced mix of polar, nonpolar, aliphatic, aromatic, negatively 
charged, and positively charged amino acids. Structurally similar amino acids 
have been excluded and there are no stop codons, thereby significantly reducing 
the number of colonies needing to be screened (59). Reetz et al. have compared 
the NNK and NDT libraries to demonstrate the differences in the number of 
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colonies that need to be screened (Figure 5.1). Reetz et al. (59) experimentally 
tested the difference between the NNK and NDT libraries and found that the 
NDT library produced higher quality results. Overall, the NDT library had more 
positive and active hits than the NNK library, and the redundancy of the positive 
hits was significantly lower than expected (59).  
 
 
Figure 5.1. The number of colonies needed in an NNK versus and NDT site-
saturation mutagenesis experiment. Data from Reetz et al. (59).  
 
 
Unfortunately, reducing the redundancy in the genetic coding used for 
SSM is the only way to decrease the number of colonies needing to be screened 
for the desired change. However, the addition of a selection step can also be used 
as a way to reduce the number of colonies to be investigated. 
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5.1.2 Selection vs. screening 
 In selection, it is assumed that the host organism experiences a growth or 
survival type advantage if it contains a gene that has been changed in some way 
to provide that advantage (62). The premise behind selection is to automatically 
eliminate the variants that are nonfunctional. Often times selection is focused on 
genes that provide some sort of nutrient that is absolutely required by the cell 
(66). However, this does not always have to be the case and this method may not 
work for every scenario. For example, while Reetz et al. (67) have used directed 
evolution techniques to change the enantioselectivity of lipases, they have also 
found that traditional selection techniques can be difficult to use to address 
enantioselectivity. To overcome this, Reetz et al. (66,67) developed a selection 
method wherein a mix of enantiomers were provided to the cells and, if the 
lipase variant catalyzed the hydrolysis of the “wrong” enantiomer, a poison 
resulted and the cells died. If the “correct” enantiomer was hydrolyzed, it acted 
as a carbon source (66,67). This method is doubly effective because lipases with 
the wrong enantioselectivity are eliminated by cell death and those with the 
correct enantioselectivity provide the carbon source that is necessary for 
growth. Clearly, using either one of these independently would be an effective 
way to select for the desired mutation.  
Despite reducing the number of colonies, selection still presents a 
problem. Once an organism is able to maintain growth using this method, there 
is no pressure for that organism to evolve further to improve its activity or 
sustainability. The McLeish laboratory has carried out some evolutionary studies 
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on ThDP-dependent enzymes (see below). Further progress now requires either 
extensive screening, or development of an efficient selection method. This 
chapter will detail some progress towards the latter goal. 
 
5.1.3 Evolution of benzoylformate decarboxylase to a pyruvate decarboxylase 
Benzoylformate decarboxylase (BFDC) catalyzes the conversion of 
benzoylformate to benzaldehyde and carbon dioxide. BFDC from Pseudomonas 
putida shares a similar structure and mechanism to all ThDP-dependent 
decarboxylases including that of ScPDC and the PDC from Zymomonas mobilis 
(ZmPDC). Mechanistically, BFDC differs from PDC only in its preference for the 
phenyl moiety of benzoylformate rather than the methyl group of pyruvate.  
Structurally, a comparison of BFDC, ZmPDC, and ScPDC reveals the 
enzymes are similar in overall protein fold, and the residues that are involved in 
the binding of ThDP. However, when looking at the residues that make up the 
active site, there is little conservation between BFDC and the two PDCs (68). 
Given the similarity in catalytic mechanism, where the only difference for any 
ThDP-dependent decarboxylase is the bulk of the preferred substrate, it would 
appear that evolution of substrate specificity is related the evolution of the 
active site architecture (16,68). Previously, Siegert et al. (69) had begun to 
explore this issue and attempted to convert a BFDC into a PDC (and vice versa). 
In that study, residues were selected for mutagenesis based on sequence 
comparisons and an overlay of the structures of the active sites. In ZmPDC, there 
are two conserved residues, Ile472 and Ile476 (Ile476 and Ile480 in ScPDC), 
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which are thought to play a role in substrate specificity (4). BFDC possesses two 
residues, Ala460 and Phe464, which could be considered direct counterparts to 
those in the two PDCs and these residues were the targeted sites for site-
directed mutagenesis.  The single and double mutants were prepared but 
overall, the experiment was largely unsuccessful (69). 
Subsequently, instead of using site-directed mutagenesis, Yep and 
McLeish (68,70) decided to employ SSM. SSM is most successful when residues 
are within 5-6 Å of the substrate (3). Based on this premise, 15 residues from 
BFDC were identified that had counterparts in PDC. Of these, 12 residues were 
used in the SSM experiment (70).  Following mutagenesis, the resulting colonies 
were screened using a microplate assay that had been designed to identify BFDC 
variants with changes in activity (68). Once the activities were determined with 
a range of substrates, the data was plotted using radar plots (Figure 5.2) and two 
variants, T377L and A460Y were identified as having a favorable change in 
activity towards pyruvate (70).  
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Figure 5.2. Radar plots illustrating the activities of the variants of the SSM 
experiments. The shape of the radar plot (red) is indicative of the substrate 
specificity change for each variant where (A) is wild-type BFDC, (B) is the A460Y 
variant, (C) is the T337L variant, and (D) is the T377L-A460Y double variant. 
The substrates tested include benzoylformate (BF), pyruvate (Pyr), 2-
ketobutanoate (2KB), 2-ketopentanoate (2KP), and 2-ketohexanoate (2KH). 
Figure taken from Yep and McLeish (70).  
 
Looking at Figure 5.2, it can be seen when comparing the individual radar 
plots that there is a clear decrease in the activity of wild-type BFDC compared to 
the variants. Wild-type BFDC (A) has better activity with the large substrates 
and none at all with pyruvate. The A460Y variant (B) had reduced activity with 
benzoylformate but significantly more activity with the smaller aliphatic 
substrates, 2-ketopentanaote and 2-ketobutanoate. The T377L variant (C) 
showed less of an effect with benzoylformate but did show enhanced activity 
with pyruvate. A second round of mutagenesis provided the T377L-A460Y 
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double variant (D) which has reduced activity overall but has the highest activity 
with pyruvate. This variant had a Km value for pyruvate of 2.0 mM and a kcat 
value of 1.8 s-1 (70). The Km value is within the range of values seen for native 
PDCs, but the kcat value is considerably (20 to 50-fold) lower. Nonetheless this is 
a solid beginning to evolving BFDC to a PDC. It remains to be seen whether the 
activity that has been developed is sufficient to replace PDC in vivo, or whether 
further optimization will be required. Both of these will require the development 
of a selection method. This chapter describes the initial approaches to that goal. 
 
 
5.2 Results and Discussion 
5.2.1 The substrate spectrum of BFDC T377L-A460Y 
BFDC T377L-A460Y was expressed and purified (section 2.4) with a yield 
of 30 mg/L active enzyme. Once purified, the protein could be stored for months 
at -80 °C without significant loss in activity. The purified enzyme was then 
assayed with a variety of substrates under steady-state conditions using the 
standard coupled assay (section 2.6.2). The results are listed in Table 5.1. 
The full steady-state kinetic study of BFDC T377L-A460Y demonstrated 
that this variant exhibited Michaelis-Menten type kinetics (Figure 5.3), which is 
consistent with wt BFDC. There was no evidence of allosteric activation nor was 
there any evidence of substrate inhibition. 
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Figure 5.3. Michaelis-Menten plot for the reaction of BFDC A460Y-T-377L with 
pyruvate. 
 
 
 
Table 5.1. Steady-state Kinetic Characterization of BFDC T377L-A460Ya 
Substrate Km (mM) kcat (s-1) kcat/Km (mM-1s-1) 
Pyruvate 4.6 ± 0.3 3.3 ± 0.1 0.72 
2-Ketobutanoate 0.39 ± 0.02 6.0 ± 0.1 16 
2-Ketopentanoate 0.15 ± 0.01 1.1 ± 0.1 7.5 
2-Ketohexanoate 0.14 ± 0.01 5.9 ± 0.2 42 
3-Methyl-2-ketobutanoate 0.77 ± 0.06 12 ± 0.4 15 
3-Methyl-2-ketopentanoate 1.2 ± 0.1 16 ± 0.7 13 
4-Methyl-2-ketopentanoate 0.14 ± 0.02 2.7 ± 0.2 20 
4-Methylthio-2-ketobutanoate 0.14 ± 0.01 4.6 ± 0.1 33 
Phenylpyruvate 0.82 ± 0.06 2.0 ± 0.1 2.5 
Benzoylformate 0.45 ± 0.04 15 ± 0.6 34 
a Values are the mean of 3 independent determinations ± standard error. 
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Overall, BFDC T377L-A460Y exhibited the greatest activity with 2-
ketohexanoate with a kcat/Km value of 42 mM-1s-1. Benzoylformate and 4-
methylthio-2-ketobutanoate (a product of methionine metabolism), had similar 
activity. Interestingly, the double mutant exhibited some level of activity with all 
substrates tested and, with the exception of pyruvate, the Km values for all 
substrates are very similar. There was more variation in the kcat values but, even 
then, they are all within an order of magnitude.  
 
Table 5.2. Kinetic values for wild-type BFDC and BFDC T377L-A460Y 
determined by Yep and McLeish. (70). 
 
  wt BFDC BFDC T377L-A460Y 
Substrate Km (mM) 
kcat      
(s-1) 
kcat/Km 
(mM-1s-1) 
Km (mM) 
kcat   
(s-1) 
kcat/Km 
(mM-1s-1) 
Pyruvate - - 0.012 2.0±0.1 
3.6±
0.3 
1.8 
2-ketobutanoate 7.5±0.6 4±1 0.5 0.42±0.02 
5.8±
0.2 
14 
2-
ketopentanoate 
6.0±0.5 11±1 1.8 0.10±0.01 
0.81
± 
0.05 
8.1 
2-ketohexanoate 4.1±0.1 
5.3±
0.3 
1.3 0.15±0.02 
1.2±
0.1 
8 
Benzoylformate 0.27±0.02 
320±
5 
1180 1.5±0.2 25±2 16 
 
The kinetic constants obtained for pyruvate, 2-ketobutanoate, 2-
ketopentanoate, 2-ketohexanoate, and benzoylformate in this study are broadly 
similar to those values determined by Yep and McLeish. (Table 5.2) (70). Taken 
together, it is clear that wt BFDC does not really accept pyruvate as a substrate 
but the double mutant displayed reasonable activity albeit significantly less than 
ScPDC (Km=1.3±0.1 mM, kcat=60±2 s-1, kcat/Km=45 mM-1s-1) and ZmPDC 
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(Km=1.1±0.1 mM, kcat=486±49 s-1, kcat/Km=440 mM-1s-1)(4). It would seem likely 
that further improvement will be required to fully convert BFDC into a good 
PDC. Potentially, this can be achieved by the use of saturation mutagenesis of 
multiple sites. However, a better selection method is needed.  
 
5.2.2 Construction of yeast expression vectors 
 As noted above, one of the downfalls of using SSM is the large number of 
colonies that must be screened to ensure that full coverage of every amino acid 
has been obtained at the site that was targeted for mutagenesis. Using selection 
over screening can mitigate this issue.  Our lab has begun developing a method 
utilizing yeast vectors for controlling expression levels in order to enhance the 
selection process and thereby address the numbers problem in SSM.  
 Mumberg et al. (25) first described a convenient series of yeast 
expression vectors that are useful in that they possess multiple restriction sites 
as well as the ability for controlling the level of gene expression. Figure 5.4 
depicts the structure of the p4XX vector series, the various promoters, and the 
marker genes (HIS3, TRP1, LEU2, URA3) that can be used. Each plasmid series, 
depending on the marker, shares the same restriction sites but vary in those that 
are single cut sites. The promoters that Mumberg et al. (25) selected to construct 
the vectors were derived from genes encoding cytochrome-c oxidase (CYC1), 
alcohol dehydrogenase (ADH), translation elongation factor 1α (TEF), and 
glyceraldehyde-3-phosphate dehydrogenase (GPD).  
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Figure 5.4. Structure of the expression vectors.  The plasmid map shows the 
location of the restriction sites between the promoter and terminator (left) and 
the marker genes (right) for each of the types of plasmid. Figure taken from 
Mumberg et al. (25). 
 
 
 Once the plasmids were constructed, the expression levels were 
determined by cloning a lacZ gene into the vectors and determining the β-
galactosidase activity under the control of each promoter (Figure 5.5). Using the 
p426 plasmid series as an example, it can be seen that the GPD promoter is the 
strongest followed by the TEF promoter, ADH promoter, and finally the CYC1 
promoter, which has the lowest activity.  
 
Figure 5.5. The expression levels of the different promoter systems determined 
by monitoring β-galactosidase activity. Figure taken from Mumberg et al. (25). 
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 This range of promoter activity is important, as one of the drawbacks of 
selection is that once an organism achieves a level of sustainability, there is no 
longer a need for the organism to evolve and improve. To alleviate this problem, 
our laboratory is developing a way to use the p426 vector system to select for 
activity after a SSM experiment. In theory, if a SSM experiment is carried out 
using the p426GPD expression vector then expression of the gene undergoing 
mutagenesis should be very high. Thus a yeast knockout could be viable with a 
relatively low level of enzyme activity. However, if the gene is placed behind the 
p426CYC1 promoter, then only those mutants with high activity should be able 
to survive. In the case of yeast, a pyruvate decarboxylase is required to be able to 
grow on a glucose media. As mentioned previously, S. cerevisiae possesses three 
genes, PDC1, PDC5, and PDC6, which are or can be capable of acting as pyruvate 
decarboxylases.  If a knockout is prepared that lacks all three PDCs, then another 
enzyme that has some PDC activity, such as the BFDC T377L-A460Y variant, 
could potentially be used to regain viability on glucose. If this, or any other 
variant placed in the p426GPD expression vector can successfully replace PDC, it 
can be tried for activity with a weaker promoter system. These BFDC variants 
could be subject to successive rounds of SSM, with the best variants being placed 
under more stringent conditions Eventually, only those variants with the highest 
activity would be obtained since they would have enough activity to overcome 
the lower expression levels.  
This process stands to greatly reduce the number of colonies needing to 
be screened in SSM by selecting for only those colonies with high levels of 
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activity and eliminating those with little to no activity. As can be seen from 
Figure 5.5, this series of vectors could potentially provide a 1000-fold change in 
expression levels.  
To explore this possibility, a series of p426GPD expression vectors was 
constructed using the methodology outlined in Figure 5.6. The p426GPD 
expression vector was the initial vector of choice as it used the strongest 
promoter. However, the available yeast PDC knockout strains used the same 
URA3 marker and, therefore, the p426 series of plasmids could not be used for 
selection without some modification. Consequently, PCR was performed to insert 
an SphI site. This enables the URA3 marker gene to be excised and the zeocin 
resistance gene inserted in its place via an SphI/ApaI digestion and ligation to 
form the p426GPD-Zeo plasmid.  
Following the addition of the zeocin cassette to the p426GPD expression 
vector, the p426GPD-Zeo plasmid was digested with BamHI and religated to 
remove extraneous EcoRI and BamHI sites. This provided the p426GPD-Zeo-
BamHI plasmid. Subsequently, a HindIII site was added via PCR mutagenesis to 
form the p426GPD-Zeo-HindIII plasmid. After this was complete, the genes for 
ScPDC1, ScPDC5, ZmPDC, BFDC, and BFDC T377L-A460Y were inserted into the 
p426GPD-Zeo-HindIII plasmid as described in section 2.3.3.  Once the plasmids 
were successfully constructed, they were used in yeast growth experiments. 
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Figure 5.6. A flowchart depicting the construction of the p426GPD-Zeo 
expression vector. E.coli was used to complete all DNA work. 
  
 
 
88 
 
8
8
 
5.2.3 Yeast growth experiments 
 Yeast PDC knockout strains (section 2.2.2) were stored at -80 °C. Fresh 
colonies were obtained by streaking on YEP plates containing 2% ethanol. These 
colonies were then streaked onto fresh YEP/2% ethanol plates as well as YPD 
plates, which contain glucose (dextrose). The knockout strains should not be 
able to grow on the YPD plates because they lack pyruvate decarboxylase 
activity and, therefore, cannot metabolize glucose. Indeed, no growth was 
observed on the YPD plates but growth was observed on the YEP/2% ethanol 
plates. This confirmed that the knockouts were indeed functional. At this point, a 
single colony was selected and a transformation (Chapter 2) was carried out 
using the plasmid pRUL178, which contains the ScPDC gene. The transformed 
cells were plated on YEP/2% ethanol and YPD plates. The results, provided in 
Figure 5.7, show the knockout yeast are unable to grow on YPD (left) but can 
maintain growth on YEP/2% ethanol (right). However, those yeast transformed 
with the plasmid containing the ScPDC are clearly able to grow on the YPD 
medium. 
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Figure 5.7. Results from the transformation of pRUL178 into the knockout yeast 
strain (5.127-17C). The 500 represent the strain number used in the laboratory 
and the 500+ indicate the knockout plus pRUL178. The YEP/2% ethanol plate 
(right) has growth with and without pRUL178 plasmid and the YPD plate (left) 
only has growth with the addition of pRUL178 plasmid.  
 
 
Subsequently, the knockout yeast (strain 5.127.17C) was transformed 
with the newly constructed plasmids and plated on YPD plates. No colonies were 
observed with the PDC5, BFDC, and BFDC T377L-A460Y transformations. 
However, transformations with the PDC1 and ZmPDC genes were successful 
(Figure 5.8). In case transformation efficiency was a problem, the 
transformations were repeated using several different protocols but the end 
result was the same each time.  
The results from this experiment answer several questions. First, the 
presence of transformants confirms that the plasmid constructs were 
successfully created. Second, as noted in the introduction, PDCs from yeast are 
allosterically activated but bacterial PDCs are not. Based on the success of the 
ZmPDC transformation, it would seem that an allosteric PDC is not required for 
successful growth of yeast. 
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Figure 5.8. Results of the p426GPD-Zeo plasmid series transformation. The top 
left is ZmPDC, top right is the untagged PDC in the pRUL178 plasmid, bottom left 
is PDC1, and bottom right the unsuccessful PDC5. There is slight contamination 
on the PDC5 transformation but the contamination is very different in 
appearance from the yeast colonies observed on the other 3 plates. 
 
 
It is not surprising that the BFDC transformation was unsuccessful given 
that BFDC has no activity with pyruvate. It was more disappointing, but not 
entirely unexpected, that the BFDC T377L-A460Y variant does not possess 
enough PDC activity to support the growth of yeast. Despite this, given that we 
have confirmed that an allosteric enzyme is not required for yeast growth, it 
would appear that an appropriately evolved BFDC variant does have the 
possibility of replacing PDC. Clearly, further rounds of mutagenesis are 
necessary to increase activity with pyruvate. Finally, perhaps the most 
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surprising/disappointing result was the lack of success of the PDC5 
transformation.  Based on the activities determined for PDC5 (Chapter 4), this 
isozyme should be able to support growth but did not. Right now, the reasons for 
this are not clear.  
In addition to the transformations described above, the same series of 
transformations, including the various conditions tried, were plated on YEP/2% 
ethanol plates with the added antibiotic (zeocin) at recommended 
concentrations (25-300 g/mL). These transformations were not successful 
with any of the plasmids nor with any of the variety of zeocin concentrations 
used. Intriguingly, wild-type baker’s yeast transformed with only a zeocin 
containing plasmid was also not able to grow on zeocin containing plates. These 
plasmids are shuttle vectors and when used with E. coli, transformants were able 
to grow on zeocin/LB plates. This suggests that the zeocin resistance factor was 
functional, just not in yeast. Given this problem, and that with the URA3 marker 
described earlier, a number of alternative knockout strains were obtained 
(CEN.PK711-7C, IMZ001, and IMZ002). These strains were checked on YPD and 
YEP/2% ethanol plates to ensure that they were not able to grow on glucose. A 
second check was carried out by transforming with the pRUL178 plasmid and 
plating on YPD as described above. Each of the strains could grow on glucose 
only if pRUL178 (containing PDC1) was present. 
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Figure 5.9. The knockout PDC yeast was transformed with pRUL178 and was 
able to grow on SD-URA media. 
 
 
The pRUL178 plasmid also contains the URA3 marker gene. The knockout 
yeast containing the pRUL178 plasmid was plated on SD media lacking uracil (-
URA) and 2% ethanol. The URA3 gene, which encodes orotidine 5'-phosphate 
decarboxylase, allows the synthesis of uracil, a component of RNA. If yeast is 
lacking the URA3 marker gene and is plated on media without uracil, they will 
not be able to grow. However, the yeast transformed with pRUL178 were able to 
grow as seen in Figure 5.9. This implies both the PDC1 and the URA3 gene were 
operational. Currently, plasmid construction of PDC1, PDC5, ZmPDC, BFDC, and 
BFDC T377L-A460Y with a URA3 marker instead of the zeocin cassette is 
underway.  
 
5.3 Conclusions and Future Directions 
 We have fully characterized BFDC T377L-A460Y and demonstrated a 
shift in the substrate specificity that is in agreement with that observed by Yep 
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and McLeish (70). Further, we have presented a plausible plan utilizing selection 
for reducing the number of colonies that need to be screened during a SSM 
experiment. We have also demonstrated that allosteric activation is not a 
requirement for yeast growth utilizing glucose as a carbon source. In the future, 
further work is needed to optimize the yeast transformation procedure to 
ensure the most efficient transformation possible. Also, plasmids will be 
constructed replacing the zeocin cassette with the URA3 gene to determine if 
that will aid in a more efficient selection method. After those steps have been 
completed, multi-site saturation mutagenesis will be employed to make new 
variants of BFDC T377L-A460Y. The newly developed selection system will be 
used to identify variants with enhanced PDC activity. 
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